fibrinogen has been researched along with Diabetes Mellitus, Adult-Onset in 350 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 19 (5.43) | 18.7374 |
1990's | 71 (20.29) | 18.2507 |
2000's | 142 (40.57) | 29.6817 |
2010's | 87 (24.86) | 24.3611 |
2020's | 31 (8.86) | 2.80 |
Authors | Studies |
---|---|
Ahmad, S; Akhter, F; Alatar, AA; Faisal, M; Hu, B; Rehman, S; Song, J | 1 |
Abidi, M; Faiz Faizy, A; Perween, S | 1 |
Aziz, IA; Basit, A; Fawwad, A; Nangrejo, R; Perveen, K; Siddiqui, IA; Waris, N | 1 |
Gao, R; Jia, S; Li, T; Song, Y; Tang, X; Wang, P; Xu, B; Xu, J; Yang, Y; Yuan, D; Yuan, J; Zeng, G; Zhang, C; Zhao, X; Zhu, P | 1 |
Akter, QS; Haque, S; Karim, F; Khanom, A; Rashid, MS | 1 |
L, H; M, RK | 1 |
Antonova, N; Paskova, V; Velcheva, I | 1 |
Fei, X; Han, F; Pan, L; Wo, M; Wu, Y; Xu, C; Ye, Y; Zhu, F | 1 |
Ardeshirrouhanifard, S; Dai, H; Li, J; Li, M; Song, Y; Zhang, X | 1 |
Guo, B; Liu, D; Song, M; Wang, B; Wang, W; Wang, Y | 1 |
Flick, MJ; Hur, WS; Juang, LJ; Kastrup, CJ; King, KC; Leung, J; Luyendyk, JP; Nguyen, YV; Patel, YN; Wei, Z; Wolberg, AS; Yang, Y | 1 |
Kell, DB; Kruger, A; Laubscher, GJ; Pretorius, E; Turner, S; Venter, C; Vlok, M | 1 |
Erasmus, RT; Hill, J; Kengne, AP; Lopes, T; Mchiza, ZJ; Peer, N; Zemlin, AE | 1 |
Cai, Q; Fu, Z; Huang, H; Zhang, J; Zhuang, Y | 1 |
Ao, P; Gu, WL; Huang, XJ; Jiang, Y; Li, ZH; Wei, L; Zhang, DF; Zhang, SQ; Zhang, XY; Zhao, X; Zhu, XB | 1 |
Dharmalingam, K; Jeya Maheshwari, J; Kannan, NB; Kohli, P; Parida, H; Ramasamy, K; Sen, S; Udaya, P | 1 |
Kong, Y; Li, X; Lu, C; Wu, Q | 1 |
Ao, P; Cao, Q; Gu, W; Huang, X; Jiang, Y; Li, Z; Sun, Y; Wang, S; Wei, L; Ye, Z; Zhang, D; Zhang, X; Zhu, X | 1 |
Cai, Y; Shang, J; Simmons, D; Wang, Z; Yu, D; Zhao, B; Zhao, Z | 1 |
Cao, P; Chan, L; Chan, P; Chang, Z; Chao, Y; Chen, Z; Deng, B; Lyu, Q; Pan, Y; Que, R; Tan, EK; Wang, Q; Wang, T; Wang, Y; Xu, L; Yang, W; Yenari, MA; Yuan, F; Zhu, S | 1 |
Dao, M; Deng, Y; Karniadakis, GE; Li, X; Mantzoros, CS; Papageorgiou, DP; Perakakis, N | 1 |
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
Deveci, B; Gazi, E | 1 |
Carr, AL; Forster, R; Grecian, SM; McLachlan, S; Price, JF; Sluiman, AJ; Strachan, MWJ | 1 |
Abunada, T; C, GPD; D, TK; Ethiraj, S; Okashah, S; Rajan, B; S, UK; V, AP; Younes, S; Zayed, H | 1 |
Bryk, AH; Undas, A; Wiśniewski, JR; Zettl, K | 1 |
Chen, JG; Peng, TW; Xu, GQ; Zhang, HB; Zhang, YH; Zhao, SC; Zuo, Y | 1 |
Ahmad, S; Alatar, AA; Alouffi, S; Faisal, M; Qahtan, AA; Rehman, S | 1 |
Barquero-Perez, O; Garcia-Carretero, R; Vigil-Medina, L | 1 |
Fei, X; Huang, Q; Ma, J; Song, Y; Wo, M; Wu, H | 1 |
Andreozzi, F; Fiorentino, TV; Mannino, GC; Marini, MA; Perticone, F; Perticone, M; Sciacqua, A; Sesti, G | 1 |
Hu, L; Liu, R; Wang, R; Xu, D; Zhao, L | 1 |
Cui, CJ; Dong, Q; Du, Y; Gao, Y; Guo, YL; Li, JJ; Li, S; Li, XL; Qing, P; Sun, J; Wu, NQ; Xu, RX; Yang, SH; Zhang, Y; Zhu, CG | 1 |
Bego, T; Čaušević, A; Dujić, T; Malenica, M; Prnjavorac, B; Semiz, S; Šilar, M; Škrbo, S | 1 |
Bilić-Ćurčić, I; Franceschi, M; Jukić, T; Makarović, S; Mihaljević, I | 1 |
Guo, R; Han, Q; Li, H; Li, L; Liu, F; Wang, S; Wang, T; Wang, Y; Wu, Y; Zhang, J; Zhang, R | 1 |
Abd-Elsalam, S; Abdelmoemen, G; Abou-Saif, S; Kassab, M; Khodeir, SA; Zaki, AN | 1 |
Hara, K; Inukai, T; Suzuki, T; Takebayashi, K; Tsuchiya, T | 1 |
Antova, E; Bosevska, G; Bosevski, M; Krstevski, G; Mitevska, I | 1 |
Fordyce, J; García, AA; Harrison, ML; Rock, J; Wolfe, AS; Zuñiga, JA | 1 |
Ebara, S; Ekawa, K; Marumo, M; Wakabayashi, I | 1 |
Chelstowski, K; Clark, JS; Jastrzebska, M; Lisman, D; Oledzki, S; Siennicka, A; Szelepajlo, A | 1 |
Bacci, S; De Cosmo, S; Pacilli, A; Trischitta, V | 1 |
Petrovič, D | 1 |
Camacho, A; Diaz, AJ; Fornieles, G; Garcia, N; Ordonez, FJ; Rosety, I; Rosety, MA; Rosety-Rodriguez, M | 1 |
Agrawal, L; Azad, N; Bahn, GD; Duckworth, W; Emanuele, NV; Hayward, R; Klein, R; McCarren, M; Reaven, P | 1 |
Adeyanju, MM; Odufuwa, KT; Osilesi, O; Salau, BA | 1 |
Chalmers, J; Hamet, P; Harrap, S; Hillis, G; Li, Q; Lowe, G; Marre, M; Patel, A; Poulter, N; Rumley, A; Woodward, M | 1 |
Poudel, S; Sapkota, B; Shrestha, SK | 1 |
Estébanez-De Miguel, E; Hidalgo-García, C; Lucha-López, AC; Lucha-López, MO; Salavera-Bordás, C; Tricás-Moreno, JM; Vidal-Peracho, C | 1 |
Abraham, P; de Roos, B; Holtrop, G; Johnstone, AM; Lobley, GE; MacRury, SM; McGeoch, SC; Megson, IL; O'Kennedy, N; Pearson, DW; Zhang, X | 1 |
Arturi, F; Fiorentino, TV; Perticone, F; Perticone, M; Sciacqua, A; Sesti, G; Succurro, E | 1 |
Abdul-Ghani, M; Cakirca, M; Camli, AA; Cikrikcioglu, MA; Erkoc, R; Hursitoglu, M; Kanat, M; Karatoprak, C; Kiskac, M; Soysal, P; Zorlu, M | 1 |
Aguilar-Sosa, E; Anaya-Gómez, F; Galván-Plata, ME; Isordia-Salas, I; Leaños-Miranda, A; Majluf-Cruz, A; Santiago-Germán, D | 1 |
Guo, YL; Hong, LF; Li, JJ; Li, XL; Luo, SH; Qing, P; Wu, NQ; Zhu, CG | 1 |
Akalin, A; Arabul, M; Celik, M; Cerrah, S | 1 |
Ajjan, RA; Alzahrani, SH; Baxter, PD; Gamlen, T; Hess, K; King, R; Oxley, N; Price, JF; Schroeder, V; Strachan, MW | 1 |
Danışman, N; Engin-Üstün, Y; Katar, C; Özyer, Ş; Uzunlar, Ö | 1 |
Breitner, S; Carter, J; Cyrys, J; Dailey, L; Devlin, RB; Diaz-Sanchez, D; Hampel, R; Koenig, W; Kraus, U; Peters, A; Phipps, R; Rückerl, R; Schneider, A; Silbajoris, R; Soentgen, J; Soukup, J | 1 |
Horobeĭko, MB | 1 |
Ajjan, RA; Grant, PJ; Grove, EL; Hvas, AM; Kristensen, SD; Kurdee, Z; Larsen, SB; Neergaard-Petersen, S; Phoenix, F | 1 |
Andreozzi, F; Fiorentino, TV; Hribal, ML; Perticone, F; Perticone, M; Sciacqua, A; Sesti, G | 1 |
Balykin, RA; Molchanov, AM; Zorina, OA | 1 |
Dai, DP; Lu, L; Shen, WF; Shen, Y; Tao, R; Xiong, WX; Zhang, Q; Zhang, RY | 1 |
Alummoottil, S; Bester, J; Buys, AV; Kell, DB; Pretorius, E; Soma, P; Vermeulen, N | 1 |
Barrett-Connor, E; Christophi, CA; Dabelea, D; Goldberg, RB; Kim, C; Marcovina, SM; Perreault, L; Pi-Sunyer, X | 1 |
Abu-Farha, M; Abubaker, J; Al-Khairi, I; Behbehani, K; Cherian, P; Elkum, N; Hu, FB; Noronha, F | 1 |
Gilowski, W; Krysiak, R; Okopien, B; Szkrobka, W | 1 |
de Las Heras Gala, T; Franks, PW; Giani, G; Herder, C; Huth, C; Klüppelholz, B; Koenig, W; Meisinger, C; Peters, A; Rathmann, W; Roden, M; Thorand, B | 1 |
Chen, X; Lv, W; Shi, X; Zheng, N | 1 |
Ahn, CW; Kang, S; Kim, KR; Lee, MY; Lee, S; Nam, JS; Park, JS; Shin, S | 1 |
Borkowska, A; Ciebiada, M; Gorska-Ciebiada, M; Loba, J; Saryusz-Wolska, M | 1 |
Beilin, LJ; Burke, V; Hodgson, JM; Mori, TA; Puddey, IB; Zilkens, RR | 1 |
Kang, Z; Wang, FJ; Yao, HQ | 1 |
Chadli, A; El Aziz, S; El Hammiri, A; Farouqi, A; Ghalim, N; Habbal, R; Kabine, M; Kamal, N; Kotbi, S; Mifdal, H; Mjabber, A; Nourichafi, N; Oukkache, B | 1 |
Chang, CJ; Hung, HC; Lu, FH; Ou, HY; Su, YC; Wu, CL; Wu, HT; Wu, JS; Yang, YC | 1 |
Breitner, S; Cyrys, J; Gu, J; Hampel, R; Koenig, W; Kraus, U; Peters, A; Rückerl, R; Schneider, A; Soentgen, J | 1 |
Gao, HL; Ley, CM; Liao, X; Ni, Q; Robinson, N | 1 |
Chehaibi, K; Mahdouani, K; Slimane, MN; Trabelsi, I | 1 |
Gligorijević, N; Nedić, O; Penezić, A | 1 |
Ajjan, RA; Alzahrani, S; Ariens, RA; Baxter, PD; Grant, PJ; Greenhalgh, KA; Price, JF; Standeven, KF; Storey, RF; Strachan, MW | 1 |
Fan, Y; Hong, LF; Li, JJ; Lu, ZH; Luo, SH; Wu, Q; Yan, XN; Yang, B; Ye, F | 1 |
Apostolopoulos, V; Bosevska, G; Bosevski, M; Stojanovska, L | 1 |
Farah, R; Lapin, O; Shurtz-Swirski, R | 1 |
Illoh, K; Illoh, OC | 1 |
Funatsu, H; Hori, S; Mimura, T; Noma, H; Shimizu, E | 1 |
Fernhall, B; Heffernan, KS; Jae, SY; Lee, MK; Park, WH | 1 |
Cornell, E; Knowler, WC; Krakoff, J; Le, DS; Miles, R; Savage, PJ; Tracy, RP | 1 |
Liese, AD; Schulz, M; Tooze, JA; Weis, KE | 1 |
Böhm, F; Hjemdahl, P; Malmström, RE; Pernow, J; Settergren, M | 1 |
Bertoni, AG; Folsom, AR; Lutsey, PL; Pankow, JS; Szklo, M | 1 |
Erem, C; Ersoz, HO; Hacihasanoglu, AB; Karti, SS; Ukinc, K | 1 |
Dogru, T; Ercin, CN; Erdem, G; Sonmez, A; Tapan, S; Tasci, I | 1 |
Krysiak, R; Okopien, B; Pruski, M | 1 |
Bouskela, E; Kraemer-Aguiar, LG; Lima, LM; Wiernsperger, N | 1 |
Boras, J; Erzen, DJ; Jazbec, A; Ljubic, S; Lovrencic, MV; Mileta, D; Vidjak, V | 1 |
Aguayo-Godinez, A; Aleman-Mireles, A; Escobedo-De la Peña, J; Guardado-Mendoza, R; Jimenez-Ceja, L; Majluf-Cruz, A; Molina-Padilla, J; Pacheco-Carrasco, MF; Villa-Godinez, G | 1 |
Jax, TW; Peters, AJ; Plehn, G; Schoebel, FC | 1 |
Demidova, VS; Doguzhieva, RM; Egorova, VV; Emel'ianov, DR; Lebedeva, AN; Pokrovskiĭ, AV; Titova, MI | 1 |
Chacko, SK; Cheluvappa, R | 1 |
Breitner, S; Frampton, MW; Hampel, R; Koenig, W; Peters, A; Phipps, RP; Rückerl, R; Schneider, A; Wichmann, HE | 1 |
Bastos, AS; Correa, FO; Figueredo, CM; Gonçalves, D; Gustafsson, A; Orrico, SR | 1 |
Abdel-Fatah Ali, A; Sayed Mahmoud And, M; Swellam, M | 1 |
Barr, RG; Bertoni, AG; Burke, GL; Carnethon, MR; Jenny, NS; Ouyang, P; Owusu, JA; Rotter, JI; Vaidya, D | 1 |
Hardison, RM; McBane, RD; Sobel, BE | 1 |
Angelopoulou, N; Fotiadis, G; Kadoglou, NP; Kapelouzou, A; Karayannacos, PE; Noussios, G; Sailer, N; Vrabas, IS | 1 |
Aschner, P; Casas, A; Charry, L; Dennis, RJ; Maldonado, D; Rojas, MX; Rondón, M | 1 |
Deng, H; Ding, Y; Liao, Y; Liu, K; Su, G; Wang, Y; Wang, Z; Zeng, Q | 1 |
Guliani, BP; Gupt, B; Kansra, UC; Madan, R; Saluja, S; Tripathi, BK | 1 |
Deary, IJ; Fowkes, FG; Gow, AJ; Harris, SE; Houlihan, LM; Lowe, GD; Luciano, M; Marioni, RE; Murray, GD; Price, JF; Rumley, A; Stewart, MC; Strachan, MW | 1 |
Ballenger, FJ; Bhola, V; Cathro, H; Kunaparaju, S; Okafor, C; Rosner, MH | 1 |
de Gorospe Pérez-Jáuregui, C; Del Cañizo Gómez, FJ; Fernández Pérez, C; González Losada, T; Moreno Ruiz, I; Segura Galindo, A; Silveira Rodríguez, B | 1 |
Masztalewicz, M; Nowacki, P; Safranow, K; Turowska-Kowalska, J | 1 |
Bălşeanu, AT; Dănoiu, S; Iancu, I; Mitran, SI; Moţa, M; Pisoschi, C; Riza, A; Sfredel, V | 1 |
Ballantyne, CM; Belalcazar, LM; Haffner, SM; Lang, W; Pi-Sunyer, FX; Rushing, J; Schwenke, DC; Tracy, RP | 1 |
Chudý, P; Kotuličová, D; Kubisz, P; Staško, J | 1 |
Azadbakht, L; Esmaillzadeh, A; Surkan, PJ; Willett, WC | 1 |
Milutinović, A; Petrovič, D; Pleskovič, A; Vraspir-Porenta, O; Zorc, M; Zorc-Pleskovič, R | 1 |
Brooks, MM; Frye, RL; Genuth, S; Hardison, RM; Huber, K; Krishnaswami, A; McBane, RD; Pratley, RE; Schneider, DJ; Sobel, BE; Wolk, R | 1 |
Borges, MA; Carvalho, MG; Fernandes, AP; Kazmi, RS; Lwaleed, BA; Rosário, PW; Soares, AL; Sousa, MO | 1 |
Aso, Y; Hara, K; Omori, K; Sumioka, Y | 1 |
Abbatecola, AM; Caruso, C; Castellani, G; Franceschi, C; Galeazzi, R; Lattanzio, F; Lisa, R; Mari, D; Monti, D; Ogliari, G; Olivieri, F; Ostan, R; Scurti, M; Sirolla, C; Spazzafumo, L; Testa, R; Vasto, S; Vescovini, R | 1 |
Antonova, N; Damianov, P; Dimitrova, V; Mantarova, S; Stoyneva, Z; Velcheva, I | 1 |
Antonova, N; Damianov, P; Mantarova, S; Velcheva, I | 1 |
Tanriverdı, O | 1 |
Athanasiadou, Z; Fotiadis, G; Kadoglou, NP; Lampropoulos, S; Vitta, I; Vrabas, IS | 1 |
Bathaie, SZ; Kebriaeezadeh, A; Khaghani, S; Mirmiranpour, H; Nakhjavani, M | 1 |
Adamson, J; Barrett, F; MacRury, SM; Megson, IL; Sharma, S; Todd, A; Zentler-Munro, PL | 1 |
Demidova, VS; Doguzhieva, RM; Lebedeva, AN; Pokrovskiĭ, AV | 1 |
Belcredi, P; Breitner, S; Carter, JD; Cyrys, J; Dailey, L; Devlin, RB; Diaz-Sanchez, D; Geruschkat, U; Hampel, R; Koenig, W; Kraus, U; Peters, A; Phipps, R; Rückerl, R; Schäuble, CL; Schneider, AE; Silbajoris, R; Soukup, J | 1 |
Breza, J; Goncalves, FM; Ziaran, S | 1 |
Dahl, M; Lange, P; Nordestgaard, BG; Thomsen, M; Vestbo, J | 1 |
Everett, B; Hensen, J; Howard, CP; Libby, P; Ridker, PM; Thuren, T; Walter, V | 1 |
Goodman, E; Oreskovic, NM | 1 |
Bosevska, G; Bosevski, M; Stojanovska, L | 1 |
Chen, X; Hu, Y; Jang, Y; Li, G; Wang, J; Xing, X; Yang, W | 1 |
Damsgaard, EM; Foss, CH; Frøland, A; Gjessing, HJ; Ingerslev, J; Mogensen, CE; Vestbo, E | 1 |
Hanefeld, M; Henkel, E; Koehler, C; Temelkova-Kurktschiev, T | 1 |
Biondi, B; Fazio, S; Lombardi, G; Nuzzo, V; Palmieri, EA; Pulcrano, M; Rossi, R; Tauchmanovà, L | 1 |
Masuda, H; Wakabayashi, I | 1 |
Boynard, M; Devehat, CL; Guillet, R; Khodabandehlou, T | 1 |
Fukushima, M; Kuroe, A; Nagasaka, S; Nakai, Y; Nin, K; Ogura, M; Okumura, T; Sakai, M; Seino, Y; Taniguchi, A; Watanabe, T; Yamada, Y; Yamadori, N; Yoshii, S | 1 |
Buchanan, TA; Chong-Martinez, B; Meiselman, HJ; Wenby, RB | 1 |
Festa, A; Kopp, CW; Kopp, HP; Kriwanek, S; Krzyzanowska, K; Minar, E; Roka, R; Schernthaner, G | 1 |
Brekke, H; Funahashi, T; Jansson, PA; Matsuzawa, Y; Pellmé, F; Smith, U; Taskinen, MR; Wiklund, O | 1 |
Tracy, RP | 1 |
Barazzoni, R; Cristini, M; Kiwanuka, E; Tessari, P; Vettore, M; Zanetti, M | 1 |
Bargero, G; Biggeri, A; Bruno, G; Cavallo Perin, P; Ferrero, S; Merletti, F; Pagano, G | 1 |
Becker, A; Bouter, LM; Heine, RJ; Stehouwer, CD; van der Does, FE; van Hinsbergh, VW | 1 |
De Maat, MP; Huisman, MV; Kluft, C; Meinders, AE; Princen, HM; Van De Ree, MA | 1 |
Bella, JN; Best, LG; Devereux, RB; Howard, BV; Liu, JE; Palmieri, V; Robbins, DC; Roman, MJ; Tracy, RP | 1 |
D'Agostino, R; Festa, A; Haffner, SM; Hanley, AJ; Tracy, RP | 1 |
Derby, C; Jannausch, ML; Pasternak, R; Sowers, M; Torrens, JI | 1 |
Alekseeva, RI; Andreenko, GV; Karabasova, MA; Liutova, LV; Meshcheriakova, VA; Plotnikova, OA; Sharafetdinov, KhKh | 1 |
Baillet, L; Gin, H; Rigalleau, V; Roudaut, MF; Vergnot, V | 1 |
Aso, Y; Inukai, T; Kanda, T; Kobayashi, I; Okumura, K; Takemura, Y; Tayama, K; Yoshida, N | 1 |
Amagasa, H; Murakami, H; Oguchi, K; Okazaki, M | 1 |
Javorský, M; Kalina, I; Kozárová, M; Salagovic, J; Tkác, I; Tkácová, R | 1 |
Jiu, G; Li, X; Liu, Y; Zhang, M | 1 |
Martin, F; Martin-Luengo, C; Morinigo, JL; Pabon, P; Palacios, IF; Piedra, I; Sanchez, PL | 1 |
Berg, C; Herrmann, BL; Mann, K; Nowak, T; Renzing-Koehler, K; Saller, B; Vogel, E | 1 |
Cieślik, G; Idzior-Waluś, B; Sieradzki, J; Waluś, M | 1 |
Keating, FK; Schneider, DJ; Sobel, BE; Whitaker, DA | 1 |
Fisher, M; Kirk, A; MacIntyre, P; Mutrie, N | 1 |
Kammerer, L; Lengyel, Z; Mihály, M; Németh, C; Rosivall, L; Tornóci, L; Tóth, LK; Vörös, P | 1 |
Aso, Y; Inoue, T; Inukai, T; Matsutomo, R; Okumura, K; Takebayashi, K; Wakabayashi, S; Yoshida, N | 1 |
Aso, Y; Inukai, T; Takebayashi, K | 1 |
Hu, FB; Rifai, N; Rimm, EB; Schulze, MB; Shai, I | 1 |
Khodabandehlou, T; Le Dévéhat, C; Vimeux, M | 3 |
Gomes, MB; Nogueira, VG | 1 |
Bartnik, M; Efendic, S; Hamsten, A; Malmberg, K; Norhammar, A; Ohrvik, J; Rydén, L; Silveira, A; Tenerz, A | 1 |
Aso, Y; Inukai, T; Matsutomo, R; Okumura, K; Takebayashi, K; Wakabayashi, S; Yoshida, N | 1 |
Dobordzhginidze, LM | 1 |
Cozma, A; Negrean, V; Sâmpelean, D; Suciu, I | 1 |
Agardh, CD; Gustavsson, CG | 1 |
Altun, A; Tatli, E; Tugrul, A; Ugur-Altun, B | 1 |
Monteduro, C; Muiesan, ML; Porteri, E; Rizzoni, D; Rosei, EA; Salvetti, M; Sleiman, I | 1 |
Akcit, F; Coban, E; Ozdogan, M; Sari, R | 1 |
Bargero, G; Biggeri, A; Bruno, G; Cavallo-Perin, P; Ferrero, S; Merletti, F; Pagano, G | 1 |
Kirbis, J; Milutinović, A; Poglajen, G | 1 |
Charvát, J; Chlumský, J; Kvapil, M; Michalová, K; Táborská, K; Vojácek, J | 1 |
Bergeron, J; Corneau, L; Lemieux, S; Nadeau, A; Piché, ME; Weisnagel, SJ | 1 |
Araki, T; Emoto, M; Fujiwara, S; Hatsuda, S; Koyama, H; Maeno, T; Nishizawa, Y; Shinohara, K; Shoji, T; Tahara, H; Yokoyama, H | 1 |
Ansquer, JC; Foucher, C; Rattier, S; Steiner, G; Taskinen, MR | 1 |
Javorský, M; Kozárová, M; Salagovic, J; Tkáč, I | 1 |
Ariëns, RA; Dunn, EJ; Grant, PJ | 1 |
Dunn, EJ; Grant, PJ | 1 |
Ciccarelli, L; Cicero, AF; Derosa, G; Ferrari, I; Gaddi, AV; Ghelfi, M; Peros, E; Piccinni, MN; Salvadeo, S | 1 |
Balletshofer, BM; Enderle, M; Ferenc Pap, A; Goebbel, S; Häring, HU; Matthaei, S; Petzinna, D; Rittig, K; Schmölzer, I; Wascher, TC; Westermeier, T | 1 |
Habeos, IG; Kyriazopoulou, V; Michalaki, M; Psyrogiannis, A; Theodoropoulou, A; Vagenakis, AG | 1 |
Aso, Y; Inukai, T; Inukai, Y; Matsumoto, S; Matsutomo, R; Takebayashi, K; Wakabayashi, S | 1 |
Hitoglou-Makedou, AD; Kazakos, KA; Lasaridis, AN; Mouslech, TF; Nilsson, PM; Sarafidis, PA; Stafylas, PC; Tourkantonis, AA; Yovos, JG | 1 |
Aunola, S; Eriksson, JG; Hämäläinen, H; Ilanne-Parikka, P; Keinänen-Kiukaanniemi, S; Lindström, J; Rastas, M; Rönnemaa, T; Tuomilehto, J; Uusitupa, M; Valle, TT; Virtanen, A | 1 |
Coppola, G; Corrado, E; Lo Coco, L; Muratori, I; Novo, S; Tantillo, R; Vitale, G | 1 |
Bevelacqua, V; Bevelacqua, Y; Libra, M; Malaponte, G; Mazzarino, MC; Navolanic, PM; Polesel, J; Signorelli, SS; Stivala, F; Talamini, R | 1 |
Barazzoni, R; Carnielli, V; Cogo, P; Gucciardi, A; Kiwanuka, E; Millioni, R; Puricelli, L; Tessari, P; Tiengo, A; Tosolini, M; Vettore, M; Zanetti, M | 1 |
Rizvi, AA | 1 |
Aso, Y; Inukai, T; Matsutomo, R; Suetsugu, M; Takebayashi, K; Wakabayashi, S | 1 |
Ariëns, RA; Dunn, EJ; Grant, PJ; Philippou, H | 1 |
Festa, A; Haffner, SM; Tracy, RP; Wagenknecht, LE; Williams, K | 1 |
Holá, D; Pálová, S; Zamrazil, V | 1 |
Barazzoni, R; Kiwanuka, E; Tessari, P; Vettore, M; Zanetti, M | 1 |
Freed, MI; Haffner, SM; Herman, WH; Holman, RR; Jones, NP; Kahn, SE; Kravitz, BG; Lachin, JM; O'Neill, MC; Viberti, GC; Yu, D; Zinman, B | 1 |
Garanty-Bogacka, B; Gebala, A; Syrenicz, A; Syrenicz, M; Walczak, M | 1 |
Coppola, G; Corrado, E; Muratori, I; Novo, S; Rizzo, M | 1 |
Arcaro, G; Bertolini, L; Cigolini, M; Padovani, R; Scala, L; Targher, G; Zenari, L | 1 |
Beishuizen, ED; Huisman, MV; Misra, A; Ray, A; Tamsma, JT | 1 |
Covic, N; Jerling, JC; Loots, du T; Pieters, M; Rheeder, P; van der Westhuizen, FH; van Zyl, DG; Weisel, JW | 1 |
Gottsche, LT; Jerling, JC; Loots, du T; Pieters, M; Rheeder, P; van der Westhuizen, FH; van Zyl, DG; Weisel, JW | 1 |
Letonturier, P | 1 |
Barontini, R; Bianchi, C; Corfini, M; Del Prato, S; Di Cianni, G; Giovannitti, MG; Malloggi, L; Miccoli, R; Penno, G | 1 |
Bianchi, C; Caricato, F; Civitelli, A; Del Prato, S; Miccoli, R; Pancani, F; Pellegrini, G; Penno, G; Piaggesi, A | 1 |
Chou, CW; Hsiao, SH; Kao, PC; Lin, CY; Ou, HY; Wu, TJ | 1 |
Avdagić, N; Fajkić, A; Lepara, O; Nakag-Ićindić, E; Valjevac, A | 1 |
Armbruster, FP; Borchert, M; Forst, T; Grabellus, M; Hohberg, C; Hoopmann, M; Löbig, M; Lübben, G; Pfützner, A; Roth, W; Schöndorf, T | 1 |
Hanefeld, M; Ludvik, B; Pacini, G | 1 |
Grant, PJ | 1 |
Malaponte, G; Mazzarino, MC; Signorelli, SS; Spandidos, DA | 1 |
Després, JP; Lemieux, I; Mertens, I; Van Gaal, LF; Verrijken, A | 1 |
Borozanov, V; Bosevski, M; Georgievska-Ismail, L; Peovska, I | 1 |
Borkowska, A; Chizyński, K; Cieplucha, E; Czupryniak, L; Loba, J; Miłosz, D; Saryusz-Wolska, M; Zasadzińska, G | 1 |
Castellino, P; Ciarambino, T; Cioffi, M; De Feo, P; Gesuè, L; Giordano, M; Gresele, P; Lucidi, P; Paolisso, G | 1 |
Haidar, A; Saad, F; Shabsigh, R; Yassin, A | 1 |
Akalin, A; Alatas, O; Colak, O | 1 |
Ahmad, I; Ahmad, J; Ahmned, F; Hameed, B; Katyal, P; Khan, AR; Siddiqui, MA | 1 |
Alizadeh Dehnavi, R; Beishuizen, ED; Huisman, MV; Kluft, C; Le Cessie, S; Princen, HM; Tamsma, JT; van de Ree, MA | 1 |
Badimón, L; Catalina, P; Gómez, JM; Sahún, M; Soler, J; Vila, R | 1 |
Baras, Y; Covic, N; Edmondson, KS; Elgar, D; Jerling, JC; Nagaswami, C; Pieters, M; Rheeder, P; Toit Loots, D; van der Westhuizen, FH; van Zyl, DG; Weisel, JW | 1 |
Fuller, JH | 1 |
Almér, LO | 1 |
Beiküfner, P; Panzram, G; Schmechel, H | 1 |
Baraldi, P; Codeluppi, L; Melli, M; Peduzzi, M; Poggi, M; Torlai, F | 1 |
Auriemma, L; Di Martino, G; Florio, A; Iannucci, F; Matarazzo, A; Rosati, V | 1 |
Hermansen, K; Ingerslev, J; Rasmussen, O; Thomsen, C | 1 |
Hermansen, K; Ingerslev, J; Rasmussen, OW; Thomsen, C | 1 |
Barker, M; Berkin, KE; Gough, SC; Grant, PJ; Rice, PJ; Smyllie, J | 1 |
Abruzzese, G; Avellone, G; Bompiani, GD; Cordova, R; De Simone, R; Di Garbo, V; Raneli, G; Rotolo, G | 1 |
Qiu, HX; Rong, J; Wang, SP | 1 |
Bruno, CM; Cristaldi, R; D'Amico, R; D'Angelo, G; Neri, S; Raciti, C | 1 |
Laitinen, J; Uusitupa, M; Vanninen, E | 1 |
Angós, JA; Cornudella, R; Gálvez, MM; Gutiérrez, M; Moreno, JA; Romero, MS | 1 |
Barker, DJ | 1 |
Griesmacher, A; Knöbl, P; Müller, M; Pietschmann, P; Prager, R; Schernthaner, G; Schnack, C | 1 |
Alberti, KG; Bahru, Y; Kesteven, P; Walker, M | 1 |
Barker, DJ; Fall, CH | 1 |
Egawa, H; Komiyama, Y; Murakami, T; Murata, K | 1 |
Memeh, CU | 1 |
Cordova, C; Gazzaninga, PP; La Mancusa, R; Pettirossi, G; Pulcinelli, FM; Spanò, GM | 1 |
Grant, PJ; Heywood, DM; Mansfield, MW | 2 |
Aoshima, K; Asakura, H; Hashimoto, T; Jokaji, H; Kumabashiri, I; Matsuda, T; Morishita, E; Saito, M; Uotani, C; Yamazaki, M | 1 |
Harano, Y; Hattori, Y; Inada, H; Inoue, J; Ito, H; Kawamori, R; Murase, T; Nawata, H; Orimo, H; Ouchi, Y; Suzuki, M; Takeuchi, M; Umeda, F | 1 |
Bots, ML; Grobbee, DE; Hofman, A; Missov, RM; Pols, HA; Stolk, RP; van der Bom, JG | 1 |
Biesenbach, G; Zazgornik, J | 1 |
de Leonardis, V; Lombardi, V; Perfetto, F; Piluso, A; Tarquini, B; Tarquini, R | 1 |
Bargero, G; Borra, M; Bruno, G; Cavallo-Perin, P; D'Errico, N; Pagano, G | 2 |
Couchman, S; Crook, MA; Tutt, P | 1 |
Cavallo-Perin, P; D'Este, P; Girotto, M; Gruden, G; Mormile, A; Rossetto, P; Veglio, M | 1 |
Carter, AM; Grant, PJ; Mansfield, MW; Stickland, MH | 1 |
Deguchi, H; Gabazza, EC; Mohri, M; Murata, K; Nakatani, K; Nishioka, J; Sata, M; Shima, T; Sumida, Y; Suzuki, K; Taguchi, O; Takeya, H; Yano, Y | 1 |
Greenhalgh, RM; Hicks, RC; Higman, DJ; Moss, J; Powell, JT | 1 |
Fujishlma, M; Iwase, M; Takano, K; Waklsaka, M; Yamamoto, M; Yoshinari, M | 1 |
Ceriello, A | 1 |
Juhan-Vague, I; Vague, P | 1 |
Jeck, T; Keller, U; Riesen, WF | 1 |
Honda, Y; Kenmochi, S; Miyamoto, K; Ogura, Y | 1 |
Molcányiová, A; Tkác, I | 1 |
Bortolotti, N; Ceriello, A; Crescentini, A; Giacomello, R; Motz, E; Pirisi, M; Russo, A; Stel, G; Taboga, C; Tonutti, L | 1 |
Byington, RP; Di Mauro, P; Guarisco, R; Pahor, M; Strollo, F; Strollo, G; Tatti, P | 1 |
Dhanjil, S; Diamond, JR; Elkeles, RS; Feher, MD; Mahmood, S; Mather, H; Nicolaides, AN; Poulter, C; Richmond, W; Sharp, P | 1 |
Kuligowska, E; Kuligowski, D; Stanosz, S | 1 |
Aznar, J; Gilsanz, A; Martínez, M; Server, R; Vayá, A | 1 |
de Leiva, A | 1 |
Ceriello, A; Damante, G; Fabbro, D; Giacomello, R; Mercuri, F; Motz, E; Stel, G; Taboga, C; Tonutti, L | 1 |
D'Agostino, R; Festa, A; Haffner, SM; Hales, CN; Mykkänen, L; Tracy, RP; Zaccaro, DJ | 1 |
Barişta, I; Demiroglu, H; Gürlek, A | 1 |
Fujiwara, Y; Kawakami, Y; Tagami, S | 1 |
Beilin, LJ; Burke, V; Dunstan, DW; Mori, TA; Morton, AR; Puddey, IB; Stanton, KG | 1 |
Eckenberger, P; Gerber, P; Ho, MP; Kaemmereit, A; Lerch, M; Teuscher, AU; Weidmann, P | 1 |
Huang, WC; Lebovitz, H; Marbury, T; Strange, P | 1 |
Bowen, K; Campbell, L; Lintott, CJ; Scott, R; Welborn, T; Zimmet, P | 1 |
Babaya, N; Fujisawa, T; Fukuda, M; Ikegami, H; Kawabata, Y; Kawaguchi, Y; Nishino, T; Nojima, K; Noso, S; Ogihara, T; Ohguro, N; Okamoto, N; Ono, M; Shintani, M; Ueda, H; Yamada, K; Yamato, E | 1 |
Kado, S; Nagase, T; Nagata, N | 1 |
Coppola, L; Cozzolino, D; De Lucia, D; Gentile, S; Masi, S; Salvatore, T; Sasso, FC; Torella, R | 1 |
Chan, LC; Janus, ED; Lam, KS; Ma, OC; Wat, NM | 1 |
Barinas-Mitchell, E; Kuller, LH; Pietropaolo, M; Pietropaolo, SL; Trucco, M | 1 |
Davis, CE; Folsom, AR; Heiss, G; Metcalf, PA; Wu, KK | 1 |
Ferber, P; Koschinsky, T; Moll, K; Rösen, P; Schwippert, B; Susanto, F; Tschöpe, D | 1 |
Din, G; Hu, J; Liu, Z; Wei, W; Yuan, L | 1 |
Ascaso, JF; Carmena, R; Hernández-Mijares, A; Lluch, I; Martínez-Triguero, ML; Vizcarra, E | 1 |
Bayraktar, M; Gürlek, A; Kirazli, S | 1 |
Brancati, FL; Chambless, LE; Duncan, BB; Folsom, AR; McGovern, PG; Saito, I | 1 |
Barazzoni, R; Carraro, P; Davanzo, G; Kiwanuka, E; Tessari, P; Tiengo, A; Zanetti, M | 1 |
D'Agostino, R; Festa, A; Haffner, SM; Howard, G; Mykkänen, L; Tracy, RP | 1 |
Chan, JC; Cockram, CS; Ko, GT; Tsang, LL | 1 |
Bulmer, K; Denver, AE; Emeis, JJ; Mohamed-Ali, V; Panahloo, A; Stehouwer, C; Yudkin, JS | 1 |
Aso, Y; Fujiwara, Y; Inukai, T; Takemura, Y | 1 |
Hedley, AJ; Janus, ED; Lam, KS; Lam, TH; Liu, LJ | 1 |
Fujita, S; Fukamizu, M; Kaizu, K; Nakajima, S; Noguchi, T; Tabuchi, M; Taka, T; Ueda, T; Yamamoto, J | 1 |
Lala, A; Menzinger, G; Montecchi, FR | 1 |
Aso, Y; Fujiwara, Y; Inukai, T; Takanashi, K; Takemura, Y; Tayama, K | 1 |
Best, JD; Cumpston, GN; Dragicevic, G; Giles, GG; Herbert, KE; O'Dea, K; Stoney, RM | 1 |
Genovese, S; Parillo, M; Rivellese, AA | 1 |
Aybar, MJ; Carrizo, T; Prado, MM; Sánchez, SS; Velarde, MS | 1 |
Aguilar-Salinas, CA; Cesarman, G; Chavira-López, IJ; Fanghänel-Salmón, G; Gallegos-Martínez, J; Gómez-Diaz, RA; Gómez-Pérez, FJ; Guillén, LE; López, A; Salinas-Orozco, S; Sánchez-Reyes, L; Tamez, R; Torres-Acosta, EM; Vázquez-Chávez, C | 1 |
Asakawa, H; Kawakami, F; Tokunaga, K | 1 |
Engelschalk, C; Fraunberger, P; Laubach, E; Otto, C; Schwandt, P | 1 |
Arber, N; Avitzour, D; Berliner, S; Elishkevitz, K; Fusman, R; Koffler, M; Rotstein, R; Shapira, I; Zeltser, D | 1 |
Bai, X; Han, Y; Ruan, C; Wang, A; Wang, Z; Zhu, M | 1 |
Aso, Y; Fujiwara, Y; Inukai, T; Matsumoto, S; Takemura, Y; Tayama, K | 1 |
D'Agostino, R; Festa, A; Haffner, SM; Tracy, RP | 1 |
Brandenburg, SL; Felder, KK; Lindenfeld, J; Manco-Johnson, M; Nelson-Wong, E; Regensteiner, JG; Reusch, JE | 1 |
Corradi, L; Derosa, G; Fogari, R; Lazzari, P; Mugellini, A; Preti, P; Zoppi, A | 1 |
Chen, J; Ding, P; Li, C; Ma, Y | 1 |
Bergmann, S; Hanefeld, M; Henkel, E; Jaross, W; Koehler, C; Siegert, G; Temelkova-Kurktschiev, T | 1 |
Athyros, VG; Athyrou, VV; Demitriadis, DS; Kontopoulos, AG; Papageorgiou, AA | 1 |
Arkin, CF; Ganda, OP | 1 |
Lazúr, J; Takác, M; Tkác, I; Tkácová, R | 1 |
Barbagallo, M; Catalano, I; Daví, G; Giammarresi, C; Nicolosi, G; Notarbartolo, A; Putignano, E; Violi, F | 1 |
Lockhart, JC; Lowe, GD; MacCuish, AC; MacRury, SM; Small, M; Weir, AI | 1 |
Ford, I; Kitchen, S; Makris, M; Preston, FE; Singh, TP; Ward, JD | 1 |
Cho, YW; Hong, SY; Huh, KB; Kim, SJ; Lee, HC; Oh, DY | 1 |
Anderson, J; Lowe, GD; MacCuish, AC; MacRury, SM; Small, M | 1 |
Barnwell, WH; Boggess, KA; Colwell, JA; Hornsby, WG; Lazarchick, J; Lyons, TJ | 1 |
Asakura, H; Jokaji, H; Kumabashiri, I; Matsuda, T; Morishita, E; Saito, M; Uotani, C; Yamazaki, M | 1 |
Konen, JC; McCormick, CP; Shihabi, ZK | 1 |
Barradas, MA; Dandona, P; Mathur, S; Mikhailidis, DP | 1 |
Ingerslev, J; Schmitz, A | 1 |
Bertoja, H; Girolami, A; Mares, M; Midena, E; Piermarocchi, S; Procidano, M; Segato, T; Zucchetto, M | 1 |
Lazúr, J; Molcányová, A; Moscovic, F; Takác, M; Tkác, I | 1 |
Memeh, CU; Reid, HL | 1 |
Karam, JH; Koda-Kimble, MA; White, JR | 1 |
Jorke, D; Jütte, A; Oswald, B; Syrbe, G | 1 |
Guo, SS; Hong, G; Liang, XC; Qian, ZF; Tao, LH; Wang, Y; Zhu, SY | 1 |
Althoff, P; Breddin, HK; Krzywanek, HJ; Schöffling, K; Uberla, K | 1 |
Khachadurian, AK; Kim, HC; Ruderman, NB; Schneider, SH | 1 |
Elkeles, RS; Feher, MD; Rampling, MW; Sever, PS | 1 |
Althoff, P; Breddin, HK; Kirchmaier, CM; Krzywanek, HJ; Rosak, C; Schepping, M; Schöffling, K; Uberla, K; Weichert, W; Ziemen, M | 1 |
Ferrari, E; Fioravanti, M; Patti, AL; Solerte, SB; Viola, C | 1 |
Boden, G; Capitanio, AM; Hershock, D; Kornecki, E; Lukasiewicz, H; Niewiarowski, S; Rawala, R | 1 |
Seviour, PW | 1 |
Forbes, CD; Lowe, GD; MacCuish, AC; Small, M | 1 |
Frank, I; Hänsgen, K; Klare, M; Podhaisky, H; Preuss, EG; Sternitzky, R | 1 |
Jones, RL | 1 |
Ferrari, E; Solerte, SB | 1 |
Duchna, W; Gräfenstein, K | 1 |
13 review(s) available for fibrinogen and Diabetes Mellitus, Adult-Onset
Article | Year |
---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Associations Between Inflammatory Markers, Hemostatic Markers, and Microvascular Complications in 182 Chinese Patients With Type 2 Diabetes Mellitus.
Topics: Adult; Aged; Antithrombin III; Asian People; C-Reactive Protein; Diabetes Mellitus, Type 2; Endothelium, Vascular; Factor VII; Female; Fibrinogen; Humans; Interleukin-6; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Regression Analysis; Statistics, Nonparametric; von Willebrand Factor | 2015 |
Inflammation, the metabolic syndrome and cardiovascular risk.
Topics: Arteriosclerosis; Aspirin; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Estrogens; Female; Fibrinogen; Humans; Hypolipidemic Agents; Male; Metabolic Syndrome; Risk Factors | 2003 |
[Fibrates: mechanism of action, effect on levels of lipids and risk of coronary events. II. Fenofibrate].
Topics: Adult; Aged; Cholesterol; Coronary Disease; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Fenofibrate; Fibrinogen; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Insulin Resistance; Lipids; Male; Middle Aged; Placebos; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Triglycerides | 2004 |
Type 2 diabetes: an atherothrombotic syndrome.
Topics: Animals; Blood Coagulation; Blood Platelets; Diabetes Mellitus, Type 2; Endothelium, Vascular; Factor VII; Factor VIII; Factor XII; Factor XIII; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Insulin Resistance; Plasminogen Activator Inhibitor 1; Syndrome; Thrombosis; Tissue Plasminogen Activator; von Willebrand Factor | 2005 |
Diabetes mellitus as a prothrombotic condition.
Topics: Blood Coagulation Factors; Blood Platelets; Diabetes Mellitus, Type 2; Endothelium, Vascular; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Hyperglycemia; Insulin Resistance; Plasminogen Activator Inhibitor 1; Risk Factors; Thrombosis; Tissue Plasminogen Activator | 2007 |
Proinflammatory circulating molecules in peripheral arterial disease.
Topics: C-Reactive Protein; Cell Adhesion Molecules; Cytokines; Diabetes Mellitus, Type 2; Fibrinogen; Humans; Inflammation Mediators; Interleukin-6; Matrix Metalloproteinases; Models, Biological; Peripheral Vascular Diseases; Polymorphism, Single Nucleotide | 2007 |
The haemocoagulation system and macroangiopathy in insulin dependent (type I) diabetes.
Topics: Antithrombin III; Arachidonic Acids; beta-Thromboglobulin; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium; Fibrinogen; Fibrinolysis; Humans; Middle Aged; Platelet Adhesiveness; Platelet Aggregation | 1984 |
The intrauterine origins of cardiovascular disease.
Topics: Adult; Animals; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Fetal Growth Retardation; Fibrinogen; Follow-Up Studies; Humans; Hypertension; Infant, Newborn; Insulin; Insulin Resistance; Lipids; Male; Maternal Welfare; Middle Aged; Nutritional Physiological Phenomena | 1993 |
Fetal and infant origins of cardiovascular disease.
Topics: Cardiovascular Diseases; Cholesterol; Diabetes Mellitus, Type 2; Female; Fetal Growth Retardation; Fibrinogen; Humans; Hypertension; Infant; Infant, Newborn; Infant, Small for Gestational Age; Male; Pregnancy; Risk Factors; Time Factors | 1993 |
Fibrinogen and diabetes mellitus: is it time for intervention trials?
Topics: Arteriosclerosis; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fibrinogen; Humans; Models, Biological; Predictive Value of Tests; Risk Factors; Thrombin | 1997 |
Fibrinogen, fibrinolysis and diabetes mellitus: a comment.
Topics: Arteriosclerosis; Biomarkers; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fibrinogen; Fibrinolysis; Humans; Plasminogen Activator Inhibitor 1; Risk Factors; Tissue Plasminogen Activator | 1997 |
What are the benefits of moderate weight loss?
Topics: Body Constitution; Body Mass Index; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diet, Reducing; Female; Fibrinogen; Gastric Bypass; Humans; Hypertension; Insulin; Male; Morbidity; Obesity; Quality of Life; Risk Factors; Weight Loss | 1998 |
62 trial(s) available for fibrinogen and Diabetes Mellitus, Adult-Onset
Article | Year |
---|---|
Correlation analysis between plasma fibrinogen and nerve electrophysiological changes in type 2 diabetic peripheral neuropathy.
Topics: Diabetes Mellitus, Type 2; Diabetic Neuropathies; Fibrinogen; Humans; Nerve Conduction Studies | 2023 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Association between angiopoietin-like protein 2 and lectin-like oxidized low-density lipoprotein receptor 1 ligand containing apolipoprotein B in patients with type 2 diabetes.
Topics: Aged; Angiopoietin-Like Protein 2; Angiopoietin-like Proteins; Apolipoproteins B; Biomarkers; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glomerular Filtration Rate; Humans; Ligands; Male; Middle Aged; Scavenger Receptors, Class E | 2018 |
Aerobic training improved low-grade inflammation in obese women with intellectual disability.
Topics: Acute-Phase Proteins; Adult; C-Reactive Protein; Cytokines; Diabetes Mellitus, Type 2; Down Syndrome; Exercise; Female; Fibrinogen; Humans; Inflammation Mediators; Interleukin-6; Obesity; Risk Factors; Tumor Necrosis Factor-alpha; Young Adult | 2014 |
Oat-enriched diet reduces inflammatory status assessed by circulating cell-derived microparticle concentrations in type 2 diabetes.
Topics: Adult; Aged; Avena; Biomarkers; Blood Platelets; Cell-Derived Microparticles; Cross-Over Studies; Diabetes Mellitus, Type 2; Diet; Female; Fibrinogen; Humans; Inflammation; Leukocytes; Male; Middle Aged; P-Selectin; Postprandial Period | 2014 |
Effect of vildagliptin add-on treatment to metformin on plasma asymmetric dimethylarginine in type 2 diabetes mellitus patients.
Topics: Adamantane; Adult; Aged; Arginine; C-Reactive Protein; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Combinations; Female; Fibrinogen; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Nitric Oxide; Nitriles; Pyrrolidines; Vildagliptin | 2014 |
[Indication and technique of human fibrinogen/thrombin-coated collagen patch use in mucogingival surgery].
Topics: Adult; Diabetes Mellitus, Type 2; Female; Fibrinogen; Gingiva; Humans; Hypertension; Male; Middle Aged; Mouth Mucosa; Oral Surgical Procedures; Re-Epithelialization; Thrombin; Wound Closure Techniques | 2014 |
Adiponectin, C-reactive protein, fibrinogen and tissue plasminogen activator antigen levels among glucose-intolerant women with and without histories of gestational diabetes.
Topics: Adiponectin; Adult; Biomarkers; Body Mass Index; C-Reactive Protein; Cohort Studies; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diabetes, Gestational; Diet, Reducing; Female; Fibrinogen; Glucose Intolerance; Humans; Hypoglycemic Agents; Life Style; Middle Aged; Motor Activity; Overweight; Pregnancy; Risk; Tissue Plasminogen Activator; United States; Weight Loss | 2016 |
The Effect of Atorvastatin on Cardiometabolic Risk Factors in Bromocriptine-Treated Premenopausal Women with Isolated Hypercholesterolemia.
Topics: Adult; Atorvastatin; Bromocriptine; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diet; Dopamine Agonists; Exercise; Female; Fibrinogen; Homocysteine; Humans; Hypercholesterolemia; Hyperprolactinemia; Hypoglycemic Agents; Hypolipidemic Agents; Metformin; Middle Aged; Premenopause; Risk Factors; Uric Acid | 2015 |
The effects of alcohol on ambulatory blood pressure and other cardiovascular risk factors in type 2 diabetes: a randomized intervention.
Topics: Aged; Alcohol Drinking; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Heart Rate; Homocysteine; Humans; Male; Middle Aged; Prospective Studies; Risk Factors; Wine | 2016 |
Bromelain and cardiovascular risk factors in diabetes: An exploratory randomized, placebo controlled, double blind clinical trial.
Topics: Blood Glucose; Bromelains; C-Reactive Protein; Cardiovascular Diseases; Demography; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fibrinogen; Humans; Lipids; Male; Middle Aged; Placebos; Risk Factors; Treatment Outcome | 2016 |
No effect of lipid lowering on platelet activity in patients with coronary artery disease and type 2 diabetes or impaired glucose tolerance.
Topics: Aged; Anticholesteremic Agents; Azetidines; C-Reactive Protein; CD40 Ligand; Cholesterol, LDL; Coronary Artery Disease; Diabetes Mellitus, Type 2; Double-Blind Method; Down-Regulation; Drug Therapy, Combination; Ezetimibe; Female; Fibrinogen; Glucose Intolerance; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; P-Selectin; Platelet Aggregation; Simvastatin; Time Factors; Treatment Outcome | 2009 |
Effects of one year simvastatin and atorvastatin treatments on acute phase reactants in uncontrolled type 2 diabetic patients.
Topics: Acute-Phase Proteins; Adult; Anticholesteremic Agents; Atorvastatin; Blood Glucose; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Ferritins; Fibrinogen; Heptanoic Acids; Humans; Male; Middle Aged; Pyrroles; Simvastatin; Time Factors | 2009 |
Pleiotropic action of short-term metformin and fenofibrate treatment, combined with lifestyle intervention, in type 2 diabetic patients with mixed dyslipidemia.
Topics: Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Combined Modality Therapy; Cytokines; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Fenofibrate; Fibrinogen; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Life Style; Metformin; Placebos; Plasminogen Activator Inhibitor 1; Risk Factors | 2009 |
Short-term treatment with metformin improves the cardiovascular risk profile in first-degree relatives of subjects with type 2 diabetes mellitus who have a metabolic syndrome and normal glucose tolerance without changes in C-reactive protein or fibrinogen
Topics: Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fibrinogen; Humans; Hypoglycemic Agents; Male; Metabolic Syndrome; Metformin; Middle Aged; Pedigree; Risk Factors; Statistics, Nonparametric | 2009 |
Comparison of plasminogen activator inhibitor-1, tissue type plasminogen activator antigen, fibrinogen, and D-dimer levels in various age decades in patients with type 2 diabetes mellitus and stable coronary artery disease (from the BARI 2D trial).
Topics: Age Factors; Aged; Autoantigens; Coronary Artery Disease; Diabetes Mellitus, Type 2; Disease Progression; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Follow-Up Studies; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Retrospective Studies; Risk Factors; Severity of Illness Index; Time Factors; Tissue Plasminogen Activator | 2010 |
Exercise ameliorates serum MMP-9 and TIMP-2 levels in patients with type 2 diabetes.
Topics: Aged; Biomarkers; C-Reactive Protein; Chi-Square Distribution; Diabetes Mellitus, Type 2; Exercise; Female; Fibrinogen; Humans; Male; Matrix Metalloproteinase 9; Middle Aged; Regression Analysis; Risk Factors; Tissue Inhibitor of Metalloproteinase-2 | 2010 |
Metabolic factors, adipose tissue, and plasminogen activator inhibitor-1 levels in type 2 diabetes: findings from the look AHEAD study.
Topics: Adipose Tissue; Adiposity; Biomarkers; Blood Glucose; Cholesterol, HDL; Diabetes Mellitus, Type 2; Diet; Exercise; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Obesity; Physical Fitness; Plasminogen Activator Inhibitor 1; Regression Analysis; Risk Reduction Behavior; Time Factors; Treatment Outcome; United States; Weight Loss | 2011 |
The Dietary Approaches to Stop Hypertension eating plan affects C-reactive protein, coagulation abnormalities, and hepatic function tests among type 2 diabetic patients.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Blood Coagulation Disorders; C-Reactive Protein; Cross-Over Studies; Diabetes Complications; Diabetes Mellitus, Type 2; Diet, Diabetic; Female; Fibrinogen; Humans; Hypertension; Liver Function Tests; Male; Middle Aged | 2011 |
Profibrinolytic, antithrombotic, and antiinflammatory effects of an insulin-sensitizing strategy in patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
Topics: Adult; Biomarkers; C-Reactive Protein; Coronary Disease; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Inflammation; Insulin; Insulin Resistance; Kaplan-Meier Estimate; Male; Metformin; Middle Aged; Myocardial Revascularization; Plasminogen Activator Inhibitor 1; Prognosis; Sulfonylurea Compounds; Thiazolidinediones; Thrombophilia; Tissue Plasminogen Activator | 2011 |
The effects of resistance training on ApoB/ApoA-I ratio, Lp(a) and inflammatory markers in patients with type 2 diabetes.
Topics: Apolipoprotein A-I; Apolipoproteins B; Biomarkers; Blood Pressure; Body Composition; Body Mass Index; C-Reactive Protein; Diabetes Mellitus, Type 2; Fibrinogen; Glycated Hemoglobin; Humans; Inflammation Mediators; Insulin Resistance; Lipids; Lipoprotein(a); Male; Middle Aged; Resistance Training; Respiratory Function Tests; Waist-Hip Ratio | 2012 |
Investigation of the mechanism(s) involved in decreasing increased fibrinogen activity in hyperglycemic conditions using L-lysine supplementation.
Topics: Adult; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Dietary Supplements; Female; Fibrinogen; Glucose; Humans; Hypoglycemic Agents; Lysine; Male; Middle Aged; Protein Binding; Treatment Outcome | 2012 |
Effects of interleukin-1β inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Biomarkers; C-Reactive Protein; Cohort Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fibrinogen; Glycated Hemoglobin; Humans; Inflammation Mediators; Interleukin-1beta; Interleukin-6; Lipid Metabolism; Male; Middle Aged; Treatment Outcome; Young Adult | 2012 |
Decreased red blood cell aggregation subsequent to improved glycaemic control in Type 2 diabetes mellitus.
Topics: Adult; Aged; Blood Glucose; Blood Viscosity; Diabetes Mellitus, Type 2; Erythrocyte Aggregation; Female; Fibrinogen; Humans; Male; Middle Aged | 2003 |
Improvement of glycaemic control in type 2 diabetes: favourable changes in blood pressure, total cholesterol and triglycerides, but not in HDL cholesterol, fibrinogen, Von Willebrand factor and (pro)insulin.
Topics: Blood Glucose; Blood Pressure; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Female; Fibrinogen; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Proinsulin; Risk Factors; Time Factors; Triglycerides; von Willebrand Factor | 2003 |
Decrease of hemostatic cardiovascular risk factors by aggressive vs. conventional atorvastatin treatment in patients with Type 2 diabetes mellitus.
Topics: Aged; Atorvastatin; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Factor VIIIa; Female; Fibrinogen; Hemostatics; Heptanoic Acids; Humans; Hyperlipidemias; Male; Middle Aged; Placebos; Pyrroles; Risk Factors; Time Factors; Tissue Plasminogen Activator; von Willebrand Factor | 2003 |
[Effect of diet therapy on status of hemocoagulation and fibrinolysis in type 2 diabetes patients].
Topics: Adult; Aged; Blood Coagulation; Blood Pressure; Caloric Restriction; Diabetes Mellitus, Type 2; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Lipoproteins, HDL; Male; Malondialdehyde; Middle Aged; Tissue Plasminogen Activator | 2003 |
Effect of metformin on fibrinolytic parameters in insulin-treated, type 2 diabetic patients.
Topics: Aged; Analysis of Variance; Blood Glucose; Cholesterol, LDL; Diabetes Mellitus, Type 2; Fibrinogen; Fibrinolysis; Fructosamine; Humans; Hypoglycemic Agents; Insulin; Metformin; Middle Aged; Plasminogen Activator Inhibitor 1 | 2003 |
Effects of a combination of recombinant human growth hormone with metformin on glucose metabolism and body composition in patients with metabolic syndrome.
Topics: Aged; Arginine; Blood Glucose; Blood Pressure; Body Composition; Body Constitution; Body Weight; Diabetes Mellitus, Type 2; Double-Blind Method; Fibrinogen; Glucose Tolerance Test; Glycated Hemoglobin; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Insulin Resistance; Insulin-Like Growth Factor I; Lipids; Male; Metabolic Syndrome; Metformin; Middle Aged; Obesity; Placebos; Testosterone | 2004 |
Effects of a 12-month physical activity counselling intervention on glycaemic control and on the status of cardiovascular risk factors in people with Type 2 diabetes.
Topics: Blood Pressure; Cardiovascular Diseases; Counseling; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Exercise; Fibrinogen; Follow-Up Studies; Humans; Oxygen Consumption; Risk Factors; Time Factors | 2004 |
Effects of candesartan cilexetil and enalapril on inflammatory markers of atherosclerosis in hypertensive patients with non-insulin-dependent diabetes mellitus.
Topics: Adult; Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Benzimidazoles; Biomarkers; Biphenyl Compounds; Blood Pressure; Diabetes Mellitus, Type 2; Double-Blind Method; Enalapril; Female; Fibrinogen; Humans; Hypertension; Intercellular Adhesion Molecule-1; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Tetrazoles; Vascular Cell Adhesion Molecule-1; von Willebrand Factor | 2005 |
Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the Diabetes Atherosclerosis Intervention Study (DAIS).
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Body Mass Index; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Double-Blind Method; Female; Fenofibrate; Fibrinogen; Follow-Up Studies; Glycated Hemoglobin; Homocysteine; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Incidence; Male; Middle Aged; Models, Biological; Smoking; Treatment Outcome | 2005 |
Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Fibrinogen; Fibrinolytic Agents; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Metabolic Syndrome; Metformin; Middle Aged; Plasminogen Activator Inhibitor 1; Rosiglitazone; Sulfonylurea Compounds; Thiazolidinediones; Tissue Plasminogen Activator | 2005 |
Intense cholesterol lowering therapy with a HMG-CoA reductase inhibitor does not improve nitric oxide dependent endothelial function in type-2-diabetes--a multicenter, randomised, double-blind, three-arm placebo-controlled clinical trial.
Topics: Blood Glucose; Blood Pressure; Brachial Artery; C-Reactive Protein; Cholesterol; Diabetes Mellitus, Type 2; Double-Blind Method; Endothelium, Vascular; Female; Fibrinogen; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Nitric Oxide; Pyridines; Triglycerides; Ultrasonography; Vasodilation | 2005 |
The effect of low-dose atorvastatin on circulating monocyte chemoattractant protein-1 in patients with type 2 diabetes complicated by hyperlipidemia.
Topics: Adult; Aged; Atorvastatin; C-Reactive Protein; Chemokine CCL2; Diabetes Mellitus, Type 2; Female; Fibrinogen; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Inflammation; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Pyrroles | 2005 |
The effect of rosiglitazone on novel atherosclerotic risk factors in patients with type 2 diabetes mellitus and hypertension. An open-label observational study.
Topics: Aged; Arteriosclerosis; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Fibrinogen; Homocysteine; Humans; Hypertension; Hypoglycemic Agents; Lipoprotein(a); Male; Middle Aged; Risk Factors; Risk Reduction Behavior; Rosiglitazone; Thiazolidinediones | 2005 |
Improved fibrinolysis by an intensive lifestyle intervention in subjects with impaired glucose tolerance. The Finnish Diabetes Prevention Study.
Topics: Adult; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet; Exercise; Female; Fibrinogen; Fibrinolysis; Finland; Follow-Up Studies; Glucose Intolerance; Humans; Life Style; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Weight Loss | 2005 |
The effect of glycaemic control on fibrin network structure of type 2 diabetic subjects.
Topics: Adult; Aged; Blood Coagulation; Blood Glucose; Diabetes Mellitus, Type 2; Female; Fibrin; Fibrinogen; Glycosylation; Humans; Insulin; Male; Middle Aged; Porosity | 2006 |
Decrease in inflammatory cardiovascular risk markers in hyperlipidemic diabetic patients treated with fenofibrate.
Topics: Atherosclerosis; Biomarkers; Blood Sedimentation; C-Reactive Protein; Cholesterol; Diabetes Mellitus, Type 2; Fenofibrate; Fibrinogen; Humans; Hyperlipidemias; Hypolipidemic Agents; Outpatients; Proinsulin; Risk Factors; Triglycerides | 2007 |
Relaxin expression correlates significantly with serum fibrinogen variation in response to antidiabetic treatment in women with type 2 diabetes mellitus.
Topics: Administration, Oral; Adult; Aged; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Humans; Hypoglycemic Agents; Male; Middle Aged; Nephelometry and Turbidimetry; Pioglitazone; Relaxin; Sex Factors; Sulfonylurea Compounds; Thiazolidinediones | 2007 |
Improved metabolic control by Ipomoea batatas (Caiapo) is associated with increased adiponectin and decreased fibrinogen levels in type 2 diabetic subjects.
Topics: Adiponectin; Blood Glucose; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Insulin; Ipomoea batatas; Male; Middle Aged; Phytotherapy | 2008 |
Decrease in von Willebrand factor levels after a high-monounsaturated-fat diet in non-insulin-dependent diabetic subjects.
Topics: alpha-Macroglobulins; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dietary Carbohydrates; Dietary Fats, Unsaturated; Endothelium, Vascular; Fatty Acids, Monounsaturated; Female; Fibrinogen; Fibronectins; Humans; Male; Middle Aged; von Willebrand Factor | 1994 |
Plasma levels of von Willebrand factor in non-insulin-dependent diabetes mellitus are influenced by dietary monounsaturated fatty acids.
Topics: alpha-Macroglobulins; Cross-Over Studies; Diabetes Mellitus, Type 2; Diet, Diabetic; Dietary Fats; Dietary Fats, Unsaturated; Fatty Acids, Monounsaturated; Fatty Acids, Unsaturated; Female; Fibrinogen; Fibronectins; Humans; Male; Middle Aged; Olive Oil; Plant Oils; von Willebrand Factor | 1995 |
Physical activity and fibrinogen concentration in newly diagnosed NIDDM.
Topics: Adult; Body Mass Index; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diet, Fat-Restricted; Energy Metabolism; Exercise; Fatty Acids; Female; Fibrinogen; Humans; Lipids; Male; Middle Aged; Regression Analysis; Smoking; Time Factors | 1994 |
Comparison of bezafibrate and simvastatin in the treatment of dyslipidaemia in patients with NIDDM.
Topics: Aged; Apolipoproteins; Bezafibrate; Creatine Kinase; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fibrinogen; Glycated Hemoglobin; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Lipoproteins; Lovastatin; Male; Middle Aged; Patient Compliance; Simvastatin | 1997 |
Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Blood Pressure; Body Mass Index; Calcium Channel Blockers; Cholesterol, HDL; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Follow-Up Studies; Fosinopril; Glycated Hemoglobin; Humans; Hypertension; Lipids; Male; Middle Aged; Prospective Studies; Time Factors | 1998 |
Cardiovascular outcomes in type 2 diabetes. A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study.
Topics: Adult; Aged; Bezafibrate; Carotid Arteries; Cholesterol; Cholesterol, HDL; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Electrocardiography; Exercise Test; Female; Femoral Artery; Fibrinogen; Follow-Up Studies; Humans; Hypolipidemic Agents; Lipids; Lipoproteins; Male; Middle Aged; Placebos; Time Factors; Triglycerides; Ultrasonography | 1998 |
[Coefficient of linear correlation between levels of fibrinogen, antithrombin III, thrombin-antithrombin complex and lipid fractions in women exposed chronically to carbon disulfide].
Topics: Adult; Antithrombin III; Blood Coagulation; Carbon Disulfide; Diabetes Mellitus, Type 2; Environmental Exposure; Environmental Monitoring; Female; Fibrinogen; Humans; Linear Models; Lipids; Middle Aged; Occupational Exposure; Risk Factors | 1998 |
A randomised, controlled study of the effects of aerobic exercise and dietary fish on coagulation and fibrinolytic factors in type 2 diabetics.
Topics: Adult; Diabetes Mellitus, Type 2; Diet, Fat-Restricted; Exercise; Factor VII; Female; Fibrinogen; Fibrinolysis; Fish Products; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Tissue Plasminogen Activator | 1999 |
Metabolic effects of temocapril in hypertensive patients with diabetes mellitus type 2.
Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Carbohydrate Metabolism; Diabetes Mellitus, Type 2; Double-Blind Method; Enalapril; Female; Fibrinogen; Humans; Hypertension; Kidney Function Tests; Lipoproteins; Male; Middle Aged; Patient Compliance; Prospective Studies; Thiazepines | 1999 |
Repaglinide versus glyburide: a one-year comparison trial.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Carbamates; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fibrinogen; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Piperidines; Prospective Studies; Triglycerides; United States; United States Food and Drug Administration | 1999 |
Will acarbose improve the metabolic abnormalities of insulin-resistant type 2 diabetes mellitus?
Topics: Acarbose; Adult; Aged; Area Under Curve; Blood Glucose; Body Mass Index; Body Weight; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Double-Blind Method; Enzyme Inhibitors; Female; Fibrinogen; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Male; Microvascular Angina; Middle Aged; Proinsulin; Random Allocation; Triglycerides; Trisaccharides | 1999 |
Short- and long-term treatments with iloprost in diabetic patients with peripheral vascular disease: effects on the cardiovascular risk factor plasminogen activator inhibitor type-1.
Topics: Aged; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Fasting; Female; Fibrinogen; Glycated Hemoglobin; Humans; Iloprost; Insulin; Male; Middle Aged; Peripheral Vascular Diseases; Pilot Projects; Plasminogen; Plasminogen Activator Inhibitor 1; Platelet Aggregation Inhibitors; Risk Factors; Time Factors; Treatment Outcome; Walking | 1999 |
High dose supplementation of RRR-alpha-tocopherol decreases cellular hemostasis but accelerates plasmatic coagulation in type 2 diabetes mellitus.
Topics: Aged; Antigens, CD; Antioxidants; Arteriosclerosis; Case-Control Studies; Cell Adhesion Molecules; Diabetes Mellitus, Type 2; Female; Fibrinogen; Hemostasis; Humans; Leukocytes; Lipoproteins, LDL; Male; Middle Aged; Oxidative Stress; Platelet Aggregation; Platelet Endothelial Cell Adhesion Molecule-1; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Vitamin E | 1999 |
Ciprofibrate effects on carbohydrate and lipid metabolism in type 2 diabetes mellitus subjects.
Topics: Adult; Aged; Apolipoproteins B; Area Under Curve; Arteriosclerosis; Blood Glucose; Carbohydrate Metabolism; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clofibric Acid; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fibric Acids; Fibrinogen; Glycated Hemoglobin; Humans; Hypolipidemic Agents; Lipid Metabolism; Lipoprotein(a); Male; Middle Aged; Triglycerides | 2000 |
Increased fibrinogen production in type 2 diabetic patients without detectable vascular complications: correlation with plasma glucagon concentrations.
Topics: Adult; Blood Glucose; Capillaries; Diabetes Mellitus, Type 2; Fibrinogen; Glucagon; Humans; Insulin; Kinetics; Leucine; Lipids; Male; Middle Aged | 2000 |
The influence of improved glycaemic control with insulin and sulphonylureas on acute phase and endothelial markers in Type II diabetic subjects.
Topics: Acute-Phase Proteins; Albuminuria; Biomarkers; Blood Glucose; C-Reactive Protein; Cross-Over Studies; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Endothelium, Vascular; Female; Fibrinogen; Fibronectins; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Interleukin-6; Male; Middle Aged; Sulfonylurea Compounds; Thrombomodulin; Tumor Necrosis Factor-alpha; von Willebrand Factor | 2000 |
Further insight on the hypoglycemic and nonhypoglycemic effects of troglitazone 400 or 600 mg/d: effects on the very-low-density and high-density lipoprotein particle distribution.
Topics: Aged; Blood Glucose; Chromans; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Fatty Acids, Nonesterified; Female; Fibrinogen; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Lipoproteins; Lipoproteins, HDL; Lipoproteins, VLDL; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Thiazoles; Thiazolidinediones; Troglitazone | 2002 |
Losartan and perindopril effects on plasma plasminogen activator inhibitor-1 and fibrinogen in hypertensive type 2 diabetic patients.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Hypertension; Losartan; Male; Middle Aged; Perindopril; Plasminogen Activator Inhibitor 1 | 2002 |
Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes.
Topics: Blood Glucose; Blood Pressure; Body Constitution; Body Mass Index; C-Reactive Protein; Causality; Diabetes Mellitus, Type 2; Female; Fibrinogen; Follow-Up Studies; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Inflammation; Insulin; Insulin Resistance; Insulin Secretion; Leukocyte Count; Male; Metabolic Syndrome; Middle Aged; Multivariate Analysis; Risk Factors | 2002 |
Atorvastatin and micronized fenofibrate alone and in combination in type 2 diabetes with combined hyperlipidemia.
Topics: Adult; Aged; Anticholesteremic Agents; Apolipoproteins; Atorvastatin; Blood Glucose; Cholesterol; Cholesterol, LDL; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Fenofibrate; Fibrinogen; Heptanoic Acids; Humans; Hyperlipidemias; Lipoprotein(a); Lipoproteins, HDL; Male; Middle Aged; Pyrroles; Triglycerides | 2002 |
The effect of a slow release formulation of bezafibrate on lipids, glucose homeostasis, platelets and fibrinogen in type II diabetics: a pilot study.
Topics: Adenosine Diphosphate; Bezafibrate; Blood Glucose; Blood Platelets; Cholesterol; Collagen; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Fibrinogen; Homeostasis; Humans; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Triglycerides | 1990 |
276 other study(ies) available for fibrinogen and Diabetes Mellitus, Adult-Onset
Article | Year |
---|---|
The Neoepitopes on Methylglyoxal- (MG-) Glycated Fibrinogen Generate Autoimmune Response: Its Role in Diabetes, Atherosclerosis, and Diabetic Atherosclerosis Subjects.
Topics: Adult; Atherosclerosis; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Male; Middle Aged; Pyruvaldehyde | 2021 |
Biophysical changes in methylglyoxal modified fibrinogen and its role in the immunopathology of type 2 diabetes mellitus.
Topics: Animals; Diabetes Mellitus, Type 2; Fibrinogen; Glycation End Products, Advanced; Glycosylation; Humans; Immunoglobulin G; Pyruvaldehyde; Rabbits | 2022 |
Association of fibrinogen and plasminogen activator inhibitor-1 with diabetes mellitus.
Topics: Adult; Case-Control Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Lipids; Male; Plasminogen Activator Inhibitor 1; Young Adult | 2022 |
High fibrinogen-to-albumin ratio with type 2 diabetes mellitus is associated with poor prognosis in patients undergoing percutaneous coronary intervention: 5-year findings from a large cohort.
Topics: Albumins; Cohort Studies; Coronary Artery Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Inflammation; Male; Percutaneous Coronary Intervention; Risk Factors; Stroke; Time Factors; Treatment Outcome | 2022 |
Estimation of Serum Fibrinogen in Males with Type 2 Diabetes.
Topics: Adult; Bangladesh; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Fibrinogen; Humans; Male; Middle Aged | 2022 |
Fibrinogen Levels in Type 2 Diabetes Mellitus and it's Correlation with Microvascular Microvascular Complications.
Topics: Albumins; Albuminuria; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Hyperglycemia; Male | 2022 |
Hemorheological and microvascular disturbances in patients with type 2 diabetes mellitus.
Topics: Blood Viscosity; Diabetes Mellitus, Type 2; Erythrocyte Aggregation; Erythrocyte Deformability; Fibrinogen; Hematocrit; Hemorheology; Humans; Microcirculation | 2022 |
Predictive significance of joint plasma fibrinogen and urinary alpha-1 microglobulin-creatinine ratio in patients with diabetic kidney disease.
Topics: Biomarkers; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Fibrinogen; Humans; Retrospective Studies | 2022 |
Associations of Nutritional, Environmental, and Metabolic Biomarkers with Diabetes-Related Mortality in U.S. Adults: The Third National Health and Nutrition Examination Surveys between 1988-1994 and 2016.
Topics: Adult; Biomarkers; C-Reactive Protein; Diabetes Mellitus, Type 2; Fibrinogen; Humans; Middle Aged; Nutrition Surveys; Thyrotropin | 2022 |
Immunoglobulin G N-glycan, inflammation and type 2 diabetes in East Asian and European populations: a Mendelian randomization study.
Topics: C-Reactive Protein; Diabetes Mellitus, Type 2; Fibrinogen; Humans; Immunoglobulin G; Inflammation; Mendelian Randomization Analysis; Polysaccharides | 2022 |
Elimination of fibrin polymer formation or crosslinking, but not fibrinogen deficiency, is protective against diet-induced obesity and associated pathologies.
Topics: Afibrinogenemia; Animals; Diabetes Mellitus, Type 2; Diet; Factor XIII; Fibrin; Fibrinogen; Hemostatics; Mice; Non-alcoholic Fatty Liver Disease; Obesity; Polymers | 2022 |
Proteomics of fibrin amyloid microclots in long COVID/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system.
Topics: alpha-2-Antiplasmin; Biomarkers; C-Reactive Protein; COVID-19; Diabetes Mellitus, Type 2; Fibrin; Fibrinogen; Humans; Interleukin-6; Plasma Kallikrein; Platelet Factor 4; Post-Acute COVID-19 Syndrome; Proteomics; Thrombosis; von Willebrand Factor | 2022 |
Consumption of Plant Foods and Its Association with Cardiovascular Disease Risk Profile in South Africans at High-Risk of Type 2 Diabetes Mellitus.
Topics: Cardiovascular Diseases; Cholesterol, LDL; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Insulins; Male; Middle Aged; Obesity; Risk Factors; South Africa; Triglycerides; Vitamin A | 2022 |
The predictive value of fibrinogen in the occurrence of mild cognitive impairment events in patients with diabetic peripheral neuropathy.
Topics: Cognitive Dysfunction; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Fibrinogen; Humans; Risk Factors | 2022 |
Role of Fibrinogen in Type-2 Diabetes Mellitus with Diabetic Neuropathy and its Preliminary Mechanism.
Topics: Animals; Constriction, Pathologic; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Fibrinogen; Male; Rats; Rats, Sprague-Dawley | 2023 |
Comparative proteomics of proliferative diabetic retinopathy in people with Type 2 diabetes highlights the role of inflammation, visual transduction, and extracellular matrix pathways.
Topics: Diabetes Mellitus, Type 2; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Extracellular Matrix; Fibrinogen; Humans; Inflammation; Proteome; Proteomics; Vision, Ocular | 2023 |
Mild cognitive impairment in type 2 diabetes is associated with fibrinogen-to-albumin ratios.
Topics: Adult; Albumins; Cognitive Dysfunction; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Male; Middle Aged; Retrospective Studies | 2023 |
A low-cost laboratory-based method for predicting newly diagnosed biopsy-proven diabetic nephropathy in people with type 2 diabetes.
Topics: Aged; Biopsy; Blood Cell Count; Blood Chemical Analysis; Blood Coagulation Tests; Blood Glucose; Blood Pressure; Body Mass Index; China; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Glycated Hemoglobin; Humans; Kidney; Male; Middle Aged; Multivariate Analysis; Partial Thromboplastin Time; Prognosis; Risk Assessment; Thrombin Time | 2020 |
Vascular, inflammatory and metabolic risk factors in relation to dementia in Parkinson's disease patients with type 2 diabetes mellitus.
Topics: Age Factors; Aged; Biomarkers; Blood Glucose; China; Cholesterol, LDL; Dementia; Diabetes Mellitus, Type 2; Female; Fibrinogen; Homocysteine; Humans; Hyperlipidemias; Inflammation; Male; Middle Aged; Parkinson Disease; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Vascular Diseases | 2020 |
Quantifying Fibrinogen-Dependent Aggregation of Red Blood Cells in Type 2 Diabetes Mellitus.
Topics: Diabetes Mellitus, Type 2; Erythrocyte Aggregation; Erythrocytes; Fibrinogen; Humans; Optical Tweezers | 2020 |
Relation Between Globulin, Fibrinogen, and Albumin With the Presence and Severity of Coronary Artery Disease.
Topics: Adult; Aged; Aged, 80 and over; Cholesterol, LDL; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glomerular Filtration Rate; Humans; Male; Middle Aged; Risk Factors; Triglycerides | 2021 |
Depression as a risk factor for dementia in older people with type 2 diabetes and the mediating effect of inflammation.
Topics: Aged; C-Reactive Protein; Dementia; Depressive Disorder; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Inflammation; Interleukin-6; Male; Mediation Analysis; Middle Aged; Proportional Hazards Models; Risk Factors; Tumor Necrosis Factor-alpha | 2021 |
Involvement of Essential Signaling Cascades and Analysis of Gene Networks in Diabesity.
Topics: Adipocytes; Angiotensinogen; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fibrinogen; Gene Regulatory Networks; Lipolysis; Obesity; Oxidative Stress; Receptor, IGF Type 1; Receptors, LDL; Renin; Shc Signaling Adaptor Proteins | 2020 |
Glycation and acetylation sites on fibrinogen in plasma fibrin clot of patients with type 2 diabetes: Effects of low-dose acetylsalicylic acid.
Topics: Acetylation; Aspirin; Diabetes Mellitus, Type 2; Fibrin; Fibrinogen; Fibrinolysis; Humans; Proteomics | 2021 |
[Vascular damage-related risk factors for erectile dysfunction in patients with type 2 diabetes mellitus: Analysis based on a nomogram model].
Topics: Carotid Intima-Media Thickness; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; Erectile Dysfunction; Erythrocyte Indices; Fibrinogen; Humans; Male; Nomograms; Risk Factors | 2020 |
Methylglyoxal mediated glycation leads to neo-epitopes generation in fibrinogen: Role in the induction of adaptive immune response.
Topics: Adaptive Immunity; Animals; Autoantibodies; Cross Reactions; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Epitopes; Female; Fibrinogen; Glycation End Products, Advanced; Glycosylation; Hyperglycemia; Immune Sera; Immunoglobulin G; Pyruvaldehyde; Rabbits | 2021 |
The Use of Machine Learning Techniques to Determine the Predictive Value of Inflammatory Biomarkers in the Development of Type 2 Diabetes Mellitus.
Topics: Biomarkers; C-Reactive Protein; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Fibrinogen; Humans; Inflammation; Insulin Resistance; Machine Learning; Predictive Value of Tests; Retrospective Studies | 2021 |
Clinical and predictive significance of Plasma Fibrinogen Concentrations combined Monocyte-lymphocyte ratio in patients with Diabetic Retinopathy.
Topics: Adult; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Disease Progression; Female; Fibrinogen; Humans; Leukocyte Count; Lymphocytes; Male; Middle Aged; Monocytes; Predictive Value of Tests; Prognosis; Risk Assessment | 2021 |
Elevated 1-h post-challenge plasma glucose levels in subjects with normal glucose tolerance or impaired glucose tolerance are associated with whole blood viscosity.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Blood Viscosity; Diabetes Mellitus, Type 2; Fasting; Female; Fibrinogen; Glucose Intolerance; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Insulin Resistance; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Risk Factors; Triglycerides | 2017 |
Influence of type 2 diabetes mellitus on Khorana venous thromboembolism risk in colorectal cancer patients.
Topics: Adult; Aged; Aged, 80 and over; China; Colorectal Neoplasms; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Male; Middle Aged; Risk; Risk Assessment; Venous Thromboembolism | 2017 |
Serum fibrinogen and cardiovascular events in Chinese patients with type 2 diabetes and stable coronary artery disease: a prospective observational study.
Topics: Aged; Beijing; C-Reactive Protein; Comorbidity; Coronary Artery Bypass; Coronary Artery Disease; Death; Diabetes Mellitus, Type 2; Female; Fibrinogen; Follow-Up Studies; Glycated Hemoglobin; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Prospective Studies; Stroke; Stroke Volume | 2017 |
Importance of inflammatory markers and IL-6 for diagnosis and follow up of patients with type 2 diabetes mellitus.
Topics: Adult; Biomarkers; C-Reactive Protein; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glucose; Glycated Hemoglobin; Humans; Inflammation; Interleukin-6; Leukocyte Count; Male; Middle Aged | 2017 |
Bone Mineral Density in Relation to Metabolic Syndrome Components in Postmenopausal Women With Diabetes Mellitus Type 2
Topics: Aged; Biomarkers; Body Mass Index; Bone Density; C-Reactive Protein; Collagen; Diabetes Mellitus, Type 2; Female; Femur; Fibrinogen; Glycated Hemoglobin; Humans; Hyperinsulinism; Insulin; Metabolic Syndrome; Middle Aged; Obesity; Obesity, Abdominal; Osteocalcin; Osteoporosis, Postmenopausal; Peptide Fragments; Plasminogen Activator Inhibitor 1; Postmenopause; Spine; Waist Circumference | 2017 |
Serum fibrinogen predicts diabetic ESRD in patients with type 2 diabetes mellitus.
Topics: Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Female; Fibrinogen; Humans; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Prognosis; Retrospective Studies | 2018 |
Overexpression of Hepassocin in Diabetic Patients with Nonalcoholic Fatty Liver Disease May Facilitate Increased Hepatic Lipid Accumulation.
Topics: Adult; Blood Glucose; Case-Control Studies; Diabetes Mellitus, Type 2; Fatty Liver; Female; Fibrinogen; Humans; Insulin; Lipid Metabolism; Liver; Male; Neoplasm Proteins; Non-alcoholic Fatty Liver Disease; Up-Regulation | 2019 |
Hyperfibrinogenemia in Peripheral Arterial Disease: Coexistent and Independent Risk Factor (A Report of Two Cases and Review of Literature).
Topics: Amputation, Surgical; Anticholesteremic Agents; Atorvastatin; Diabetes Mellitus, Type 2; Fenofibrate; Fibrinogen; Humans; Hypolipidemic Agents; Intermittent Claudication; Ischemia; Lower Extremity; Male; Middle Aged; Peripheral Arterial Disease; Predictive Value of Tests; Risk Factors; Treatment Outcome | 2018 |
The additive effect of type 2 diabetes on fibrinogen, von Willebrand factor, tryptophan and threonine in people living with HIV.
Topics: Biomarkers; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; HIV; HIV Infections; Humans; Male; Middle Aged; Risk Factors; Threonine; Tryptophan; von Willebrand Factor | 2019 |
Inverse association between habitual alcohol drinking and d-dimer in patients with type 2 diabetes mellitus.
Topics: Aged; Aged, 80 and over; Alcohol Drinking; Blood Coagulation; Body Mass Index; Cholesterol, HDL; Diabetes Mellitus, Type 2; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Glycated Hemoglobin; Humans; Male; Middle Aged; Risk Factors; Smoking | 2020 |
Evaluation of platelet reactivity during combined antiplatelet therapy in patients with stable coronary artery disease in relation to diabetes type 2 and the GPIIB/IIIA receptor gene polymorphism.
Topics: Blood Platelets; Clopidogrel; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Integrin beta3; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Polymorphism, Genetic; Prospective Studies; Thromboxane B2 | 2019 |
Role of relationship between HbA1c, fibrinogen and HDL-cholesterol on cardiovascular disease in patients with type 2 diabetes mellitus.
Topics: Aged; Atherosclerosis; Cardiovascular Diseases; Cholesterol, HDL; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glycated Hemoglobin; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Risk Factors | 2013 |
Association of the -262C/T polymorphism in the catalase gene promoter and the C242T polymorphism of the NADPH oxidase P22phox gene with essential arterial hypertension in patients with diabetes mellitus type 2.
Topics: Aged; C-Reactive Protein; Case-Control Studies; Catalase; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Genetic Predisposition to Disease; Glutathione Peroxidase; Humans; Hypertension; Male; Middle Aged; NADPH Oxidases; Oxidative Stress; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Risk Factors; Slovenia | 2014 |
Association of PAI-1 and fibrinogen with diabetic retinopathy in the Veterans Affairs Diabetes Trial (VADT).
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Fibrinogen; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Prospective Studies; Veterans | 2014 |
Fruits and vegetables diet improves some selected haemorheological parameters predisposing to cardiovascular disease in non insulin dependent diabetes mellitus NIDDM subjects.
Topics: Blood Sedimentation; Blood Viscosity; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus, Type 2; Diet; Fibrinogen; Fruit; Hematocrit; Hemorheology; Humans; Nigeria; Risk Factors; Vegetables | 2012 |
Circulating inflammatory markers and the risk of vascular complications and mortality in people with type 2 diabetes and cardiovascular disease or risk factors: the ADVANCE study.
Topics: Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Humans; Interleukin-6; Male; Middle Aged; Risk Factors | 2014 |
Association of activated partial thromboplastin time and fibrinogen level in patients with type II diabetes mellitus.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Hospitals, Teaching; Humans; Hypoglycemic Agents; Male; Middle Aged; Nepal; Partial Thromboplastin Time; Tertiary Healthcare | 2013 |
Analysis of a sample of type 2 diabetic patients with obesity or overweight and at cardiovascular risk: a cross sectional study in Spain.
Topics: Age of Onset; Anthropometry; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Comorbidity; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diet; Female; Fibrinogen; Glycated Hemoglobin; Humans; Hypertension; Insulin; Life Style; Lipids; Male; Middle Aged; Motor Activity; Obesity; Overweight; Risk Factors; Spain | 2014 |
Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with unfavorable inflammatory profile.
Topics: Adult; Aged; Asymptomatic Diseases; Blood Glucose; Blood Sedimentation; C-Reactive Protein; Cardiovascular Diseases; Chronic Disease; Complement C3; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glucose Tolerance Test; Humans; Inflammation; Male; Metabolome; Middle Aged; Prediabetic State; Risk Factors; Time Factors | 2014 |
Proinflammatory and prothrombotic state in subjects with different glucose tolerance status before cardiovascular disease.
Topics: Adult; Aged; Biomarkers; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Early Diagnosis; Female; Fibrinogen; Glucose Intolerance; Glycated Hemoglobin; Humans; Male; Mexico; Middle Aged; Overweight; Prediabetic State; Risk Factors; Thrombosis; Vasculitis | 2014 |
Association of fibrinogen with severity of stable coronary artery disease in patients with type 2 diabetic mellitus.
Topics: Adult; Aged; Angina, Stable; Area Under Curve; Biomarkers; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Male; Middle Aged; Multivariate Analysis; Prospective Studies; ROC Curve; Severity of Illness Index | 2014 |
Relation of asymmetric dimethylarginine levels to macrovascular disease and inflammation markers in type 2 diabetic patients.
Topics: Aged; Arginine; Atherosclerosis; Biomarkers; Blood Sedimentation; C-Reactive Protein; Carotid Intima-Media Thickness; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Homocysteine; Humans; Inflammation Mediators; Male; Middle Aged; Regression Analysis; Systemic Vasculitis; Up-Regulation | 2014 |
Hypofibrinolysis in type 2 diabetes: the role of the inflammatory pathway and complement C3.
Topics: Aged; C-Reactive Protein; Complement C3; Diabetes Mellitus, Type 2; Female; Fibrinogen; Fibrinolysis; Humans; Inflammation; Male; Middle Aged; Plasminogen Activator Inhibitor 1 | 2014 |
Inflammation and glycemic tolerance status in pregnancy: the role of maternal adiposity.
Topics: Adiposity; Blood Glucose; Body Mass Index; C-Reactive Protein; Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Ferritins; Fibrinogen; Glucose Intolerance; Glucose Tolerance Test; Humans; Inflammation; Insulin Resistance; Interleukin-6; Leukocyte Count; Obesity; Pregnancy; Risk Factors | 2014 |
Associations between ambient air pollution and blood markers of inflammation and coagulation/fibrinolysis in susceptible populations.
Topics: Adult; Aged; Air Pollutants; Air Pollution; Biomarkers; Blood Coagulation; C-Reactive Protein; CD40 Antigens; Diabetes Mellitus, Type 2; Female; Fibrinogen; Fibrinolysis; Germany; Glutathione Transferase; Humans; Inflammation; Male; Middle Aged; Particulate Matter; Peroxidase; Polymorphism, Single Nucleotide | 2014 |
[Determination of efficacy of second application of Urokinase Medac in a diabetic foot syndrome].
Topics: Blood Gas Monitoring, Transcutaneous; Diabetes Mellitus, Type 2; Diabetic Foot; Drug Administration Schedule; Fibrinogen; Humans; Ischemia; Leg; Re-Epithelialization; Treatment Outcome; Urokinase-Type Plasminogen Activator | 2014 |
The influence of type 2 diabetes on fibrin clot properties in patients with coronary artery disease.
Topics: Aged; Aspirin; Blood Coagulation Tests; C-Reactive Protein; Case-Control Studies; Complement C3; Coronary Artery Disease; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrin; Fibrinogen; Fibrinolysis; Humans; Inflammation Mediators; Male; Microscopy, Confocal; Microscopy, Electron, Scanning; Middle Aged; Nephelometry and Turbidimetry; Platelet Aggregation Inhibitors; Registries; Risk Factors; Sex Factors; Time Factors | 2014 |
Unfavorable inflammatory profile in adults at risk of type 2 diabetes identified by hemoglobin A1c levels according to the American Diabetes Association criteria.
Topics: Adult; Aged; American Medical Association; Association; Biomarkers; Blood Glucose; Blood Sedimentation; C-Reactive Protein; Complement C3; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Male; Middle Aged; Prediabetic State; United States | 2015 |
Clinical utility of the ratio between circulating fibrinogen and fibrin (ogen) degradation products for evaluating coronary artery disease in type 2 diabetic patients.
Topics: Aged; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Fibrin; Fibrinogen; Humans; Male; Middle Aged | 2015 |
Poorly controlled type 2 diabetes is accompanied by significant morphological and ultrastructural changes in both erythrocytes and in thrombin-generated fibrin: implications for diagnostics.
Topics: Adult; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Erythrocytes; Female; Fibrinogen; Humans; Male; Middle Aged; Random Allocation; Thrombin | 2015 |
Higher plasma betatrophin/ANGPTL8 level in Type 2 Diabetes subjects does not correlate with blood glucose or insulin resistance.
Topics: Adult; Age Factors; Aged; Angiopoietin-Like Protein 8; Angiopoietin-like Proteins; Blood Glucose; Body Mass Index; Case-Control Studies; Cholesterol, LDL; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Lipid Metabolism; Male; Middle Aged; Peptide Hormones; Risk Factors; Waist-Hip Ratio | 2015 |
Association of subclinical inflammation with deterioration of glycaemia before the diagnosis of type 2 diabetes: the KORA S4/F4 study.
Topics: Acute-Phase Proteins; Adiponectin; Aged; Biomarkers; Blood Glucose; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Inflammation; Interleukin-6; Male; Middle Aged; Prospective Studies; Serum Amyloid A Protein | 2015 |
Hemorheological Approach for Early Detection of Chronic Kidney Disease and Diabetic Nephropathy in Type 2 Diabetes.
Topics: Albuminuria; Biomarkers; Creatinine; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Early Diagnosis; Erythrocyte Aggregation; Erythrocyte Deformability; Fasting; Female; Fibrinogen; Glomerular Filtration Rate; Humans; Male; Middle Aged; Regression Analysis; Renal Insufficiency, Chronic | 2015 |
Plasma levels of thrombomodulin, plasminogen activator inhibitor-1 and fibrinogen in elderly, diabetic patients with depressive symptoms.
Topics: Aged; Biomarkers; Cholesterol, LDL; Depression; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Male; Neuropsychological Tests; Plasminogen Activator Inhibitor 1; Prospective Studies; Risk Factors; Statistics as Topic; Thrombomodulin | 2016 |
Effects of Endovascular Interventions on vWF and Fb Levels in Type 2 Diabetic Patients with Peripheral Artery Disease.
Topics: Aged; Angioplasty, Balloon; Biomarkers; Blood Coagulation; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Humans; Male; Peripheral Arterial Disease; Prothrombin Time; Stents; Time Factors; Treatment Outcome; Up-Regulation; von Willebrand Factor | 2016 |
Correlation between the plasma fibrinogen concentration and coronary heart disease severity in Moroccan patients with type 2 diabetes. Prospective study.
Topics: Aged; Aged, 80 and over; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Humans; Male; Middle Aged; Morocco; Prospective Studies; Risk Factors; Severity of Illness Index | 2016 |
A novel hepatokine, HFREP1, plays a crucial role in the development of insulin resistance and type 2 diabetes.
Topics: Aged; Animals; Blood Glucose; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glucose Intolerance; Hep G2 Cells; Humans; Insulin; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Middle Aged; Neoplasm Proteins | 2016 |
Association of novel metrics of particulate matter with vascular markers of inflammation and coagulation in susceptible populations -results from a panel study.
Topics: Aged; Air Pollutants; Blood Coagulation; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glucose Intolerance; Glutathione Transferase; Humans; Inflammation; Interleukin-6; Male; Middle Aged; Particulate Matter; Peroxidase; Polymorphism, Single Nucleotide | 2016 |
Correlation of Oxidative Stress Parameters and Inflammatory Markers in Ischemic Stroke Patients.
Topics: Aged; Biomarkers; Blood Glucose; Brain Ischemia; C-Reactive Protein; Diabetes Mellitus, Type 2; Erythrocytes; Female; Fibrinogen; Glutathione Peroxidase; Glycated Hemoglobin; Humans; Inflammation Mediators; Lipids; Male; Middle Aged; Oxidative Stress; Predictive Value of Tests; Prognosis; Stroke; Superoxide Dismutase | 2016 |
Influence of glyco-oxidation on complexes between fibrin(ogen) and insulin-like growth factor-binding protein-1 in patients with diabetes mellitus type 2.
Topics: Aged; Blood Glucose; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glycated Hemoglobin; Humans; Insulin-Like Growth Factor Binding Protein 1; Male; Middle Aged; Oxidation-Reduction; Protein Binding | 2017 |
BβArg448Lys polymorphism is associated with altered fibrin clot structure and fibrinolysis in type 2 diabetes.
Topics: Aged; Blood Coagulation Tests; Diabetes Mellitus, Type 2; Female; Fibrin; Fibrinogen; Fibrinolysis; Genetic Association Studies; Genotype; Humans; Male; Microscopy, Electron, Scanning; Middle Aged; Phenotype; Polymorphism, Genetic; Protein Conformation; Risk Assessment; Risk Factors; Scotland; Structure-Activity Relationship; Thrombosis | 2017 |
Predictive value of non-fasting remnant cholesterol for short-term outcome of diabetics with new-onset stable coronary artery disease.
Topics: Aged; Biomarkers; C-Reactive Protein; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clopidogrel; Cohort Studies; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Fibrinogen; Follow-Up Studies; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Neutrophils; Prognosis; Proportional Hazards Models; ROC Curve; Ticlopidine; Treatment Outcome | 2017 |
CRP and fibrinogen imply clinical outcome of patients with Type-2 diabetes and coronary artery disease.
Topics: Angina Pectoris; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Diabetes Mellitus, Type 2; Fibrinogen; Humans; Inflammation; Prognosis; Prospective Studies | 2017 |
Intensification of oxidative stress and inflammation in type 2 diabetes despite antihyperglycemic treatment.
Topics: Adult; Aged; Apoptosis; C-Reactive Protein; Case-Control Studies; CD11b Antigen; Diabetes Mellitus, Type 2; Fibrinogen; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Inflammation; Insulin; Leukocytes, Mononuclear; Metformin; Middle Aged; Oxidative Stress; Rosiglitazone; Superoxides; Thiazolidinediones; Transferrin | 2008 |
Thrombolytic-associated coagulopathy and management dilemmas: a review of two cases.
Topics: Aged; Aged, 80 and over; Case Management; Cerebral Hemorrhage; Diabetes Mellitus, Type 2; Factor VIII; Female; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Hypertension; Infarction, Middle Cerebral Artery; International Normalized Ratio; Intubation, Intratracheal; Partial Thromboplastin Time; Recombinant Proteins; Thrombolytic Therapy; Tissue Plasminogen Activator | 2008 |
Association between serum lipoprotein (a) level and progression of non-proliferative diabetic retinopathy in Type 2 diabetes.
Topics: Aged; Asian People; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Disease Progression; Female; Fibrinogen; Follow-Up Studies; Fundus Oculi; Glycated Hemoglobin; Humans; Lipoprotein(a); Male; Middle Aged; Predictive Value of Tests; Risk Assessment; Systole; Time Factors | 2009 |
Relation of cardiorespiratory fitness to inflammatory markers, fibrinolytic factors, and lipoprotein(a) in patients with type 2 diabetes mellitus.
Topics: Age Factors; Biomarkers; Body Fat Distribution; C-Reactive Protein; Cardiovascular Physiological Phenomena; Cholesterol; Diabetes Mellitus, Type 2; Exercise Test; Fibrinogen; Humans; Leukocyte Count; Lipoprotein(a); Male; Middle Aged; Oxygen Consumption; Physical Fitness; Plasminogen Activator Inhibitor 1; Respiratory Physiological Phenomena; Tissue Plasminogen Activator | 2008 |
The association of plasma fibrinogen concentration with diabetic microvascular complications in young adults with early-onset of type 2 diabetes.
Topics: Adult; Albumins; Biomarkers; Cardiovascular Diseases; Creatinine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Fibrinogen; Humans; Indians, North American; Inflammation; Microcirculation | 2008 |
Food intake patterns associated with incident type 2 diabetes: the Insulin Resistance Atherosclerosis Study.
Topics: Adult; Aged; Biomarkers; Blood Glucose; Cohort Studies; Diabetes Mellitus, Type 2; Energy Intake; Feeding Behavior; Female; Fibrinogen; Follow-Up Studies; Glucose Tolerance Test; Humans; Incidence; Inflammation; Insulin; Insulin Resistance; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Regression Analysis; Risk Factors; Surveys and Questionnaires | 2009 |
Serological evidence of infections and Type 2 diabetes: the MultiEthnic Study of Atherosclerosis.
Topics: Aged; Aged, 80 and over; C-Reactive Protein; Chlamydophila Infections; Chlamydophila pneumoniae; Cross-Sectional Studies; Cytomegalovirus; Cytomegalovirus Infections; Diabetes Mellitus, Type 2; Female; Fibrinogen; Helicobacter Infections; Helicobacter pylori; Hepatitis A; Hepatitis A Virus, Human; Herpes Simplex; Humans; Immunoglobulin G; Interleukin-6; Male; Middle Aged; Risk Factors; Seroepidemiologic Studies; Simplexvirus; United States | 2009 |
NASH and cardiovascular biomarkers.
Topics: Adiponectin; Biomarkers; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Fatty Liver; Fibrinogen; Humans; Intra-Abdominal Fat; Obesity; Plasminogen Activator Inhibitor 1; Predictive Value of Tests; Triglycerides | 2009 |
Adiponectin has different mechanisms in type 1 and type 2 diabetes with C-peptide link.
Topics: Adiponectin; Adult; C-Peptide; C-Reactive Protein; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Fibrinogen; Humans; Middle Aged; Triglycerides; Uric Acid | 2009 |
Fibrinogen is associated with silent myocardial ischaemia in type 2 diabetes mellitus.
Topics: Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Ischemia | 2009 |
Hemostatic risk factors in patients with coronary artery disease and type 2 diabetes - a two year follow-up of 243 patients.
Topics: Acute Coronary Syndrome; Angina Pectoris; Blood Viscosity; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus, Type 2; Erythrocyte Aggregation; Fibrinogen; Fibrinolysis; Follow-Up Studies; Hemorheology; Humans; Hypercholesterolemia; Incidence; Myocardial Infarction; Myocardial Revascularization; Plasminogen Inactivators; Risk Factors; Thrombophilia | 2009 |
[Assessment of the level of homocysteine and the state of haemostasis in patients with and without type 2 diabetes mellitus in remote terms after reconstructive operations on the aorto-iliac segment].
Topics: Aged; Antithrombin III; Aorta, Abdominal; Blood Vessel Prosthesis Implantation; Data Interpretation, Statistical; Diabetes Mellitus, Type 2; Female; Fibrinogen; Follow-Up Studies; Hemostasis; Homocysteine; Humans; Iliac Artery; Leg; Male; Middle Aged; Plastic Surgery Procedures; Platelet Aggregation; Postoperative Complications; Thromboplastin; Time Factors | 2009 |
Increased ceruloplasmin and fibrinogen in type 2 diabetes corresponds to decreased anti-oxidant activity in a preliminary tertiary South Indian hospital study.
Topics: Adult; Aged; Aging; Alcohol Drinking; Antioxidants; Ceruloplasmin; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glycated Hemoglobin; Humans; India; Inflammation; Male; Middle Aged; Oxidative Stress; Pilot Projects; Sex Characteristics; Smoking; Young Adult | 2010 |
Air temperature and inflammatory and coagulation responses in men with coronary or pulmonary disease during the winter season.
Topics: Aged; Biomarkers; Blood Coagulation; C-Reactive Protein; Coronary Disease; Diabetes Mellitus, Type 2; Fibrinogen; Germany; Health Status Indicators; Humans; Lung Diseases; Male; Middle Aged; Risk Factors; Seasons; Temperature | 2010 |
Effect of periodontal treatment on metabolic control, systemic inflammation and cytokines in patients with type 2 diabetes.
Topics: Adult; Blood Glucose; C-Reactive Protein; Chronic Periodontitis; Cytokines; Dental Plaque Index; Dental Scaling; Diabetes Mellitus, Type 2; Female; Fibrinogen; Follow-Up Studies; Gingival Hemorrhage; Glycated Hemoglobin; Humans; Inflammation Mediators; Interleukin-10; Interleukin-4; Interleukin-6; Interleukin-8; Male; Middle Aged; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Root Planing; Tumor Necrosis Factor-alpha | 2010 |
Clinical implications of adiponectin and inflammatory biomarkers in type 2 diabetes mellitus.
Topics: Adiponectin; Adult; Aged; Aged, 80 and over; Biomarkers; Body Mass Index; C-Reactive Protein; Cohort Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Inflammation; Kidney; Lasers, Gas; Lipids; Male; Middle Aged; Risk Factors; Sensitivity and Specificity; Vascular Diseases | 2009 |
Inflammation and the incidence of type 2 diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA).
Topics: Aged; Aged, 80 and over; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Incidence; Inflammation; Interleukin-6; Male; Middle Aged; United States | 2010 |
Inadequate glucose control in type 2 diabetes is associated with impaired lung function and systemic inflammation: a cross-sectional study.
Topics: Adult; Aged; Biomarkers; Blood Glucose; C-Reactive Protein; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Ferritins; Fibrinogen; Glycated Hemoglobin; Humans; Hyperglycemia; Inflammation; Interleukin-6; Lung Diseases; Male; Middle Aged; Respiratory Function Tests; Tumor Necrosis Factor-alpha | 2010 |
Expression and significance of fgl2 prothrombinase in cardiac microvascular endothelial cells of rats with type 2 diabetes.
Topics: Animals; Coronary Vessels; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Endothelial Cells; Fibrinogen; Male; Microvessels; Myocardial Ischemia; Rats; Rats, Sprague-Dawley; Thromboplastin; Thrombosis; Tumor Necrosis Factor-alpha | 2010 |
Coagulation profile in diabetes and its association with diabetic microvascular complications.
Topics: Adult; Age Factors; Aged; Blood Coagulation Factors; Blood Coagulation Tests; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Neuropathies; Diabetic Retinopathy; Endothelium, Vascular; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1 | 2010 |
Genetic associations between fibrinogen and cognitive performance in three Scottish cohorts.
Topics: Aged; Aging; Aspirin; Atherosclerosis; Cognition; Cognition Disorders; Cohort Studies; Cross-Sectional Studies; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Fibrinogen; Genotype; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Scotland | 2011 |
Proteinuria in a patient with diabetes.
Topics: Amyloidosis, Familial; Biopsy; Diabetes Mellitus, Type 2; DNA Mutational Analysis; Fibrinogen; Humans; Kidney Diseases; Kidney Glomerulus; Male; Middle Aged; Mutation; Proteinuria | 2011 |
Microvascular complications and risk factors in patients with type 2 diabetes.
Topics: Aged; Albuminuria; Anthropometry; Antihypertensive Agents; Blood Glucose; C-Reactive Protein; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Female; Fibrinogen; Follow-Up Studies; Glycated Hemoglobin; Habits; Humans; Hypoglycemic Agents; Lipids; Male; Microcirculation; Middle Aged; Prospective Studies; Risk Factors | 2011 |
[Peripheral blood indicators of inflammatory response during the first twenty-four hours of ischemic stroke].
Topics: Aged; Biomarkers; Brain Ischemia; C-Reactive Protein; Diabetes Mellitus, Type 2; Dyslipidemias; Female; Fibrinogen; Humans; Hypertension; Inflammation Mediators; Leukocyte Count; Male; Stroke; Tumor Necrosis Factor-alpha | 2010 |
Correlations between abdominal circumference and the breakage resistance of the fibrin clot in patients with diabetes mellitus type 2.
Topics: Aged; Brain Ischemia; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Hyperlipidemias; Male; Middle Aged; Myocardial Infarction; Obesity, Abdominal; Platelet Activation; Thrombophilia; Thrombosis; Time; Waist Circumference | 2010 |
The relationship among TAFI, t-PA, PAI-1 and F1 + 2 in type 2 diabetic patients with normoalbuminuria and microalbuminuria.
Topics: Aged; Albuminuria; Blood Coagulation; Blood Pressure; Body Mass Index; Carboxypeptidase B2; Case-Control Studies; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Hypertension; Male; Middle Aged; Peptide Fragments; Plasminogen Activator Inhibitor 1; Prothrombin; Sex Factors; Slovakia; Thrombin; Tissue Plasminogen Activator | 2011 |
Deficiency of mast cells in coronary artery endarterectomy of male patients with type 2 diabetes.
Topics: Aged; Coronary Artery Bypass; Coronary Artery Disease; Coronary Vessels; Diabetes Mellitus, Type 2; Endarterectomy; Fibrin; Fibrinogen; Fluorescent Antibody Technique; Humans; Hypertension; Immunoglobulin G; Male; Mast Cells; Middle Aged; Pilot Projects; Slovenia; Staining and Labeling | 2011 |
Elevated plasma factor VIII and von Willebrand factor in women with type 2 diabetes: inflammatory reaction, endothelial perturbation or else?
Topics: Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Carotid Intima-Media Thickness; Diabetes Mellitus, Type 2; Endothelium, Vascular; Factor VIII; Female; Fibrinogen; Humans; Inflammation; Middle Aged; Thrombomodulin; Tunica Intima; Ultrasonography, Doppler, Color; von Willebrand Factor | 2011 |
Spontaneous platelet aggregation evaluated by laser light scatter in patients with type 2 diabetes: effects of short-term improved glycemic control and adiponectin.
Topics: Adiponectin; Adult; Aged; Area Under Curve; Blood Glucose; Blood Platelets; C-Reactive Protein; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperglycemia; Hypoglycemic Agents; Lasers; Male; Metformin; Middle Aged; Platelet Aggregation; Platelet Count; Scattering, Radiation; Serum Albumin; Sulfonylurea Compounds | 2012 |
Remodelling of biological parameters during human ageing: evidence for complex regulation in longevity and in type 2 diabetes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Analysis of Variance; Biomarkers; Blood Glucose; C-Reactive Protein; Chi-Square Distribution; Cholesterol; Diabetes Mellitus, Type 2; Factor Analysis, Statistical; Female; Fibrinogen; Hematologic Tests; Hemoglobins; Humans; Italy; Leukocyte Count; Longevity; Male; Middle Aged; Principal Component Analysis; Triglycerides | 2013 |
Hemorheology and vascular reactivity in patients with diabetes mellitus type 2.
Topics: Adult; Aged; Blood Flow Velocity; Body Mass Index; Cerebrovascular Circulation; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Neuropathies; Erythrocyte Indices; Female; Fibrinogen; Hemorheology; Humans; Lipids; Male; Middle Aged; Middle Cerebral Artery; Posture; Skin; Toes; Ultrasonography | 2011 |
Hemorheology and heart rate variability in patients with diabetes mellitus type 2.
Topics: Adult; Aged; Blood Flow Velocity; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Neuropathies; Female; Fibrinogen; Fourier Analysis; Glycated Hemoglobin; Heart Rate; Hemorheology; Humans; Lipids; Male; Middle Aged; Posture; Rest; Stress, Mechanical | 2011 |
Association of Helicobacter pylori infection with microalbuminuria in type 2 diabetic patients.
Topics: Adult; Aged; Albuminuria; Blood Sedimentation; C-Reactive Protein; Case-Control Studies; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Female; Fibrinogen; Helicobacter Infections; Helicobacter pylori; Humans; Leukocyte Count; Lipoprotein(a); Logistic Models; Male; Middle Aged; Platelet Count; Statistics, Nonparametric | 2011 |
Diabetic fatty liver disease is associated with specific changes in blood-borne markers.
Topics: Adiponectin; Aged; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Biomarkers; Cholesterol; Collagen Type I; Diabetes Mellitus, Type 2; Fatty Liver; Female; Fibrinogen; Humans; Hyaluronic Acid; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Peptides; Triglycerides | 2012 |
[Hyperhomocysteinemia and plasma acute-phase proteins in patients with type 2 diabetes mellitus and severe course of atherosclerosis after vascular operations].
Topics: Atherosclerosis; C-Reactive Protein; Diabetes Mellitus, Type 2; Disease Progression; Female; Fibrinogen; Glycated Hemoglobin; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Male; Middle Aged; Postoperative Complications; Risk Assessment; Severity of Illness Index; Statistics as Topic; Vascular Surgical Procedures | 2011 |
Short-term effects of air temperature on blood markers of coagulation and inflammation in potentially susceptible individuals.
Topics: Adult; Aged; Air; Biomarkers; Blood Coagulation; Body Mass Index; C-Reactive Protein; Diabetes Mellitus, Type 2; Exercise; Female; Fibrinogen; Germany; Glucose Intolerance; Glucose Metabolism Disorders; Humans; Inflammation; Inflammation Mediators; Interleukin-5; Male; Middle Aged; Obesity; Plasminogen; Polymorphism, Genetic; Prospective Studies; Sex Factors; Temperature; Time Factors | 2012 |
Patients with prostate cancer treated by ADT have significantly higher fibrinogenemia than healthy control.
Topics: Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Fibrinogen; Gonadotropin-Releasing Hormone; Humans; Insulin Resistance; Male; Middle Aged; Prospective Studies; Prostatic Neoplasms; Testosterone; Triglycerides | 2013 |
Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease.
Topics: Aged; Biomarkers; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Fibrinogen; Forced Expiratory Volume; Heart Failure; Humans; Inflammation Mediators; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Pneumonia; Pulmonary Disease, Chronic Obstructive; Risk; Vital Capacity | 2012 |
Association of optimism with cardiometabolic risk in adolescents.
Topics: Biomarkers; Black or African American; Blood Glucose; Body Mass Index; Cardiovascular Diseases; Character; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Fibrinogen; Humans; Insulin; Interleukin-6; Lipids; Massachusetts; Motivation; Personality Inventory; Puberty; Risk Factors; Smoking; White People | 2013 |
Influence of fibrinogen and C-RP on progression of peripheral arterial disease in type 2 diabetes: a preliminary report.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Cohort Studies; Diabetes Mellitus, Type 2; Disease Progression; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Peripheral Arterial Disease; Prospective Studies | 2013 |
Obesity, coronary heart disease risk factors and diabetes in Chinese: an approach to the criteria of obesity in the Chinese population.
Topics: Adult; Aged; Anthropometry; Asian People; Blood Glucose; Blood Pressure; China; Cholesterol, HDL; Coronary Disease; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Hypertension; Hypertriglyceridemia; Male; Middle Aged; Obesity; Prevalence; Prospective Studies; Risk Factors; Sex Distribution; Triglycerides | 2002 |
Insulin resistance is accompanied by increased von Willebrand factor levels in nondiabetic women: a study of offspring of type 2 diabetic subjects compared to offspring of nondiabetic subjects.
Topics: Case-Control Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Fibronectins; Humans; Insulin Resistance; Logistic Models; Male; Middle Aged; von Willebrand Factor | 2002 |
Leukocyte count and fibrinogen are associated with carotid and femoral intima-media thickness in a risk population for diabetes.
Topics: Adult; Aged; Analysis of Variance; Arteriosclerosis; Carotid Artery, Common; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Femoral Artery; Fibrinogen; Humans; Leukocyte Count; Male; Middle Aged; Multivariate Analysis; Risk Factors; Tunica Intima; Tunica Media | 2002 |
Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aged; Arteriosclerosis; Blood Glucose; Blood Pressure; Body Constitution; Body Mass Index; Cardiovascular Diseases; Carotid Arteries; Cholesterol; Cushing Syndrome; Diabetes Mellitus, Type 2; Diastole; Fasting; Female; Fibrinogen; Glucose Intolerance; Humans; Hyperlipidemias; Hypertension; Insulin; Insulin Resistance; Male; Middle Aged; Risk Factors; Systole; Triglycerides; Ultrasonography | 2002 |
Relation of serum sialic acid to blood coagulation activity in type 2 diabetes.
Topics: Adult; Aged; Aged, 80 and over; Arteriosclerosis; Biomarkers; Blood Coagulation; Cohort Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Japan; Male; Middle Aged; N-Acetylneuraminic Acid; Platelet Count; Risk Factors | 2002 |
Sensitivity of the ultrasonic interferometry method (Echo-Cell) to changes of red cell aggregation: application to diabetes.
Topics: Adult; Biophysical Phenomena; Biophysics; Blood Sedimentation; Dextrans; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Equipment Design; Erythrocyte Aggregation; Erythrocytes; Female; Fibrinogen; Hemorheology; Humans; Interferometry; Male; Middle Aged; Sensitivity and Specificity; Ultrasonics; Ultrasonography | 2002 |
C-reactive protein and insulin resistance in non-obese Japanese type 2 diabetic patients.
Topics: Asian People; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Fibrinogen; Homeostasis; Humans; Insulin Resistance; Japan; Lipids; Male; Middle Aged; Thinness | 2002 |
Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients.
Topics: Adult; Blood Glucose; Body Mass Index; C-Reactive Protein; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Gastroplasty; Humans; Inflammation; Insulin; Insulin Resistance; Interleukin-6; Lipids; Longitudinal Studies; Male; Middle Aged; Obesity, Morbid; Tumor Necrosis Factor-alpha; Weight Loss | 2003 |
Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients.
Topics: Adiponectin; Adipose Tissue; Adult; Blood Glucose; Blood Pressure; Body Constitution; C-Reactive Protein; Diabetes Mellitus, Type 2; Family; Fasting; Fibrinogen; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin Secretion; Intercellular Signaling Peptides and Proteins; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Proinsulin; Proteins; Reference Values | 2003 |
Insulin acutely increases fibrinogen production in individuals with type 2 diabetes but not in individuals without diabetes.
Topics: Amino Acids; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Fibrinogen; Glucagon; Humans; Insulin; Male; Middle Aged; Reference Values; Triglycerides | 2003 |
Progression to overt nephropathy in type 2 diabetes: the Casale Monferrato Study.
Topics: Aged; Albuminuria; Apolipoproteins B; Biomarkers; Cholesterol, HDL; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Female; Fibrinogen; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypertension; Male; Patient Selection; Prospective Studies; Regression Analysis; Risk Factors; Smoking; Time Factors | 2003 |
Relation of left ventricular hypertrophy to inflammation and albuminuria in adults with type 2 diabetes: the strong heart study.
Topics: Aged; Albuminuria; Arteriosclerosis; Biomarkers; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Hypertrophy, Left Ventricular; Incidence; Indians, North American; Inflammation; Male; Middle Aged; Prevalence; Risk Factors; Thrombosis | 2003 |
Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion.
Topics: Adipose Tissue; Arteriosclerosis; Body Composition; Body Mass Index; C-Reactive Protein; Diabetes Mellitus, Type 2; Disease Susceptibility; Female; Fibrinogen; Follow-Up Studies; Glucose Tolerance Test; Humans; Incidence; Inflammation; Insulin; Insulin Resistance; Insulin Secretion; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Prediabetic State; Risk Factors | 2003 |
Insulin resistance, hemostatic factors, and hormone interactions in pre- and perimenopausal women: SWAN.
Topics: Adult; Climacteric; Diabetes Mellitus, Type 2; Estradiol; Factor VII; Female; Fibrinogen; Follicle Stimulating Hormone; Hemostasis; Humans; Insulin Resistance; Middle Aged; Plasminogen Activator Inhibitor 1; Premenopause; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone; Tissue Plasminogen Activator | 2003 |
Plasma interleukin-6 is associated with coagulation in poorly controlled patients with Type 2 diabetes.
Topics: Blood Coagulation; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hospitalization; Humans; Insulin; Interleukin-6; Male; Middle Aged; Sulfonylurea Compounds | 2003 |
Increase in hepatic mRNA expression of coagulant factors in type 2 diabetic model mice.
Topics: Animals; Blood Coagulation Factors; Diabetes Mellitus, Type 2; Disease Models, Animal; DNA, Complementary; Fibrinogen; Mice; Mice, Mutant Strains; Prothrombin; Reference Values; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription, Genetic | 2003 |
Angiotensin-converting enzyme genotype, albuminuria and plasma fibrinogen in type 2 diabetes mellitus.
Topics: Aged; Albuminuria; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Female; Fibrinogen; Genotype; Glycated Hemoglobin; Humans; Male; Middle Aged; Peptidyl-Dipeptidase A; Perindopril; Polymerase Chain Reaction; Polymorphism, Genetic; Risk Factors; Smoking | 2003 |
[Effect of danshen injection on expression of platelet membrane glycoproteins in patients with type II diabetes mellitus].
Topics: Adult; Aged; Blood Platelets; Child, Preschool; Diabetes Mellitus, Type 2; Drugs, Chinese Herbal; Female; Fibrinogen; Flow Cytometry; Humans; Male; Middle Aged; P-Selectin; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Membrane Glycoproteins; Salvia miltiorrhiza | 2003 |
Prognostic relations between inflammatory markers and mortality in diabetic patients with non-ST elevation acute coronary syndrome.
Topics: Aged; Angina, Unstable; Biomarkers; C-Reactive Protein; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Humans; Leukocyte Count; Male; Multivariate Analysis; Myocardial Infarction; Prognosis; Spain; Survival Analysis | 2004 |
[Homocysteine and C-reactive protein concentrations in serum of diabetic patients].
Topics: Aged; Blood Glucose; Body Mass Index; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Creatinine; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glycated Hemoglobin; Homocysteine; Humans; Lipids; Male; Middle Aged; Sex Factors; Triglycerides | 2003 |
Augmentation of inhibitory effects of glycoprotein IIb-IIIa antagonists in patients with diabetes.
Topics: Abciximab; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Blood Platelets; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glycosylation; Humans; Immunoglobulin Fab Fragments; Kinetics; Male; Membrane Proteins; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Time Factors | 2004 |
Urinary albumin excretion is correlated to fibrinogen levels and protein S activity in patients with type 1 diabetes mellitus without overt diabetic nephropathy.
Topics: Adult; Age Factors; Albuminuria; Blood Coagulation Tests; Body Mass Index; Data Interpretation, Statistical; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; Female; Fibrinogen; Humans; Male; Middle Aged; Protein S; Sex Factors | 2004 |
Results of blood inflammatory markers are associated more strongly with toe-brachial index than with ankle-brachial index in patients with type 2 diabetes.
Topics: Aged; Ankle Joint; Biomarkers; Blood Flow Velocity; Brachial Artery; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Fibrinogen; Functional Laterality; Humans; Inflammation; Interleukin-6; Male; Middle Aged; Plethysmography; Regression Analysis; Reproducibility of Results; Toes | 2004 |
Initiation of insulin therapy reduces serum concentrations of high-sensitivity C-reactive protein in patients with type 2 diabetes.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Body Constitution; Body Weight; C-Reactive Protein; Chemokine CCL2; Diabetes Mellitus, Type 2; Fasting; Female; Fibrinogen; Humans; Injections, Subcutaneous; Insulin; Male; Middle Aged; Regression Analysis; Smoking; Time Factors | 2004 |
Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes.
Topics: Adiponectin; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Fibrinogen; Humans; Inflammation; Intercellular Signaling Peptides and Proteins; Life Style; Lipids; Male; Receptors, Tumor Necrosis Factor, Type II; Statistics, Nonparametric | 2004 |
Blood rheology in patients with diabetes mellitus.
Topics: Adult; Blood Glucose; Blood Viscosity; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Erythrocyte Aggregation; Female; Fibrinogen; Glycated Hemoglobin; Hemorheology; Humans; Male; Middle Aged | 2004 |
Acute-phase proteins and microalbuminuria among patients with type 2 diabetes.
Topics: Acute-Phase Proteins; Age of Onset; Albuminuria; Blood Proteins; C-Reactive Protein; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Fibrinogen; Humans; Male; Middle Aged; Orosomucoid; Reference Values; Regression Analysis | 2004 |
Abnormal glucose tolerance--a common risk factor in patients with acute myocardial infarction in comparison with population-based controls.
Topics: Acute Disease; Blood Glucose; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Hyperlipidemias; Hypertension; Insulin Resistance; Lipids; Male; Myocardial Infarction; Proinsulin; Prospective Studies; Risk Factors; Triglycerides | 2004 |
Coagulation and inflammation in overt diabetic nephropathy: association with hyperhomocysteinemia.
Topics: Albuminuria; alpha-2-Antiplasmin; Biomarkers; Blood Coagulation; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Interleukin-6; Linear Models; Male; Middle Aged; Protein C | 2004 |
Rheological changes in diabetic microangiopathy.
Topics: Biomarkers; Blood Glucose; Blood Platelets; Blood Viscosity; Cell Adhesion; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Erythrocyte Aggregation; Erythrocyte Deformability; Female; Fibrinogen; Hematocrit; Hemorheology; Humans; Male; Middle Aged | 2004 |
Markers of inflammation in patients with coronary artery disease are also associated with glycosylated haemoglobin A1c within the normal range.
Topics: Aged; Biomarkers; Blood Glucose; Blood Sedimentation; Body Mass Index; C-Reactive Protein; Coronary Artery Disease; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Glycated Hemoglobin; Humans; Leukocyte Count; Male; Middle Aged; Reference Values | 2004 |
Factors related to exercise capacity in asymptomatic middle-aged type 2 diabetic patients.
Topics: Adult; Coronary Disease; Diabetes Mellitus, Type 2; Electrocardiography; Exercise; Exercise Test; Fasting; Female; Fibrinogen; Heart Rate; Homeostasis; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Obesity; Prospective Studies; Sex Characteristics; Smoking | 2005 |
Levels of plasma fibrinogen and d-dimer in patients with impaired fasting glucose.
Topics: Adult; Blood Glucose; Case-Control Studies; Diabetes Mellitus, Type 2; Fasting; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged | 2005 |
Fibrinogen and AER are major independent predictors of 11-year cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study.
Topics: Aged; Albuminuria; Biomarkers; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fibrinogen; Follow-Up Studies; Humans; Italy; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Regression Analysis; Risk; Time Factors | 2005 |
The -455G/A polymorphism of the beta fibrinogen gene and the Bgl II polymorphism of the alpha2beta1 integrin gene and myocardial infarction in patients with type 2 diabetes.
Topics: Bacterial Proteins; Deoxyribonucleases, Type II Site-Specific; Diabetes Mellitus, Type 2; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Integrin alpha2beta1; Male; Myocardial Infarction; Polymorphism, Genetic; White People | 2004 |
[Relation between diabetes compensation, albuminuria and biochemical parameters and the results of stress myocardial SPECT in asymptomatic type 2 diabetics].
Topics: Albuminuria; C-Reactive Protein; Coronary Circulation; Coronary Disease; Diabetes Mellitus, Type 2; Exercise Test; Female; Fibrinogen; Homocysteine; Humans; Male; Middle Aged; Tomography, Emission-Computed, Single-Photon; Uric Acid | 2004 |
Contribution of abdominal visceral obesity and insulin resistance to the cardiovascular risk profile of postmenopausal women.
Topics: Adipose Tissue; Aged; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Insulin Resistance; Interleukin-6; Lipids; Middle Aged; Obesity; Postmenopause; Risk | 2005 |
The K469E polymorphism of the intercellular adhesion molecule-1 gene is associated with plasma fibrinogen level in type 2 diabetes.
Topics: Albuminuria; Blood Pressure; Carotid Arteries; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Exons; Female; Femoral Artery; Fibrinogen; Genotype; Humans; Insulin Resistance; Intercellular Adhesion Molecule-1; Male; Middle Aged; Polymorphism, Genetic; Regression Analysis; Ultrasonography | 2005 |
Relationship among urinary albumin excretion rate, lipoprotein lipase PvuII polymorphism and plasma fibrinogen in type 2 diabetic patients.
Topics: Albuminuria; Diabetes Mellitus, Type 2; Female; Fibrinogen; Genotype; Humans; Linear Models; Lipoprotein Lipase; Male; Middle Aged; Polymorphism, Genetic | 2006 |
The influence of type 2 diabetes on fibrin structure and function.
Topics: Blood Coagulation; Body Mass Index; Body Size; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Factor XIII; Female; Fibrin; Fibrinogen; Humans; Hypoglycemic Agents; Lipids; Male; Middle Aged; Reference Values; Risk Factors | 2005 |
Insulin sensitivity and fibrinogen concentrations in normoglycaemic offspring of Type 2 diabetic parents.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glucose Tolerance Test; Humans; Insulin; Male; Middle Aged | 2005 |
Lipid, lipoproteins, C-reactive protein, and hemostatic factors at baseline in the diabetes prevention program.
Topics: C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glucose Intolerance; Homeostasis; Humans; Lipoproteins; Male; Middle Aged; Regression Analysis; Risk Factors; Tissue Plasminogen Activator; Triglycerides | 2005 |
Increased levels of C-reactive protein and fibrinogen influence the risk of vascular events in patients with NIDDM.
Topics: Aged; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Cerebrovascular Disorders; Chi-Square Distribution; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Male; Prevalence; Risk Factors | 2006 |
Analysis of G(-174)C IL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease.
Topics: Aged; C-Reactive Protein; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Genetic Predisposition to Disease; Genotype; Humans; Interleukin-6; Male; Middle Aged; Peripheral Vascular Diseases; Polymorphism, Genetic; Vascular Endothelial Growth Factor A | 2006 |
Albumin and fibrinogen synthesis and insulin effect in type 2 diabetic patients with normoalbuminuria.
Topics: Adult; Case-Control Studies; Diabetes Mellitus, Type 2; Fibrinogen; Glucagon; Humans; Hypertension; Hypoglycemic Agents; Insulin; Leucine; Male; Serum Albumin | 2006 |
The role of inflammation in diabetes and its complications.
Topics: Atherosclerosis; Biomarkers; C-Reactive Protein; Diabetes Mellitus, Type 2; Fibrinogen; Humans; Inflammation; Interleukins; Risk Factors; Serum Amyloid A Protein | 2006 |
Correlation of high-sensitivity C-reactive protein and plasma fibrinogen with individual complications in patients with type 2 diabetes.
Topics: Biomarkers; C-Reactive Protein; Carotid Artery, Common; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Electrocardiography; Female; Fibrinogen; Humans; Male; Middle Aged; Sensitivity and Specificity; Severity of Illness Index; Tunica Intima; Ultrasonography | 2006 |
Molecular mechanisms involved in the resistance of fibrin to clot lysis by plasmin in subjects with type 2 diabetes mellitus.
Topics: Aged; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Drug Resistance; Enzyme Activation; Factor XIII; Female; Fibrin; Fibrinogen; Fibrinolysin; Glycated Hemoglobin; Hemolysis; Humans; Male; Mass Spectrometry; Middle Aged; Reference Values; Surface Plasmon Resonance | 2006 |
Progression of plasminogen activator inhibitor-1 and fibrinogen levels in relation to incident type 2 diabetes.
Topics: Adult; Aged; Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease Progression; Female; Fibrinogen; Glucose Tolerance Test; Humans; Incidence; Male; Middle Aged; Plasminogen Activator Inhibitor 1 | 2006 |
[The meaning of the combination of fibrinogen, micro/macroalbuminuria and atheromatosis in the carotid bloodstream for the evaluation of the abnormal finding of the stress myocardial SPECT in the asymptomatic 2nd type diabetic patients].
Topics: Albuminuria; Atherosclerosis; Carotid Arteries; Carotid Artery Diseases; Coronary Circulation; Coronary Disease; Diabetes Mellitus, Type 2; Dipyridamole; Female; Fibrinogen; Heart Ventricles; Humans; Male; Middle Aged; Tomography, Emission-Computed, Single-Photon; Ultrasonography | 2006 |
Diabetic nephropathy is associated with increased albumin and fibrinogen production in patients with type 2 diabetes.
Topics: Albuminuria; C-Reactive Protein; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Fibrinogen; Humans; Middle Aged; Serum Albumin | 2006 |
Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes.
Topics: Adiposity; Blood Glucose; Body Mass Index; C-Reactive Protein; Diabetes Mellitus, Type 2; Fasting; Female; Fibrinogen; Fibrinolysis; Glycated Hemoglobin; Homeostasis; Humans; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Obesity; Plasminogen Activator Inhibitor 1 | 2006 |
Low-grade systemic inflammation and the risk of type 2 diabetes in obese children and adolescents.
Topics: Adolescent; Biomarkers; Blood Glucose; C-Reactive Protein; Child; Child, Preschool; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Inflammation; Insulin; Interleukin-1beta; Interleukin-6; Leukocyte Count; Male; Obesity; Risk Factors; Triglycerides | 2006 |
Association of elevated fibrinogen and C-reactive protein levels with carotid lesions in patients with newly diagnosed hypertension or type II diabetes.
Topics: C-Reactive Protein; Carotid Arteries; Carotid Artery Diseases; Diabetes Mellitus, Type 2; Fibrinogen; Humans; Hypertension; Tunica Media | 2006 |
Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients.
Topics: Age Factors; Atherosclerosis; Calcifediol; Carotid Artery, Common; Case-Control Studies; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Male; Middle Aged; Prevalence; Regression Analysis; Risk Factors; Sex Factors; Smoking; Tunica Media; Ultrasonography; Vitamin D Deficiency | 2006 |
Vascular phenotype and subclinical inflammation in diabetic Asian Indians without overt cardiovascular disease.
Topics: Adult; Aged; Anthropometry; Asian People; C-Reactive Protein; Cardiovascular Diseases; Carotid Arteries; Diabetes Mellitus, Type 2; Electrocardiography; Female; Fibrinogen; Humans; Inflammation; Male; Middle Aged; Netherlands; Phenotype; Suriname | 2007 |
Glycation of fibrinogen in uncontrolled diabetic patients and the effects of glycaemic control on fibrinogen glycation.
Topics: Adult; Black People; Blood Glucose; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glycated Hemoglobin; Glycosylation; Humans; Insulin; Male; Middle Aged | 2007 |
[Postprandial glycemia in diabetes patients: assessing this indicator].
Topics: Administration, Inhalation; Administration, Oral; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Postprandial Period; Pregnancy; Pregnancy in Diabetics; Risk Factors; Time Factors; Tumor Necrosis Factor-alpha | 2006 |
Non-traditional markers of atherosclerosis potentiate the risk of coronary heart disease in patients with type 2 diabetes and metabolic syndrome.
Topics: Aged; Atherosclerosis; Biomarkers; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Creatinine; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glycated Hemoglobin; Humans; Italy; Male; Metabolic Syndrome; Middle Aged; Odds Ratio; Prevalence; Risk Assessment; Risk Factors; Serum Albumin; Uric Acid | 2008 |
Non-traditional cardiovascular risk factors contribute to peripheral arterial disease in patients with type 2 diabetes.
Topics: Aged; Ankle; Blood Pressure; Brachial Artery; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glycated Hemoglobin; Humans; Italy; Logistic Models; Male; Middle Aged; Peripheral Vascular Diseases; Prevalence; Pulse; Risk Factors; Smoking | 2007 |
[Metabolic syndrome and plasma fibrinogen in type 2 diabetic patients].
Topics: Aged; Aged, 80 and over; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Lipids; Male; Metabolic Syndrome; Middle Aged | 2007 |
PAI-1 activity, but not fibrinogen or von Willebrand factor, is inversely related to LDL particle size in type 2 diabetes.
Topics: Aged; Apolipoproteins B; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Hyperinsulinism; Intra-Abdominal Fat; Lipoproteins, LDL; Male; Middle Aged; Particle Size; Phenotype; Plasminogen Activator Inhibitor 1; Tomography, X-Ray Computed; von Willebrand Factor | 2008 |
Endothelial dysfunction correlates with plasma fibrinogen and HDL cholesterol in type 2 diabetic patients with coronary artery disease.
Topics: Cholesterol, HDL; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium, Vascular; Fibrinogen; Humans; Middle Aged | 2007 |
[Adiponectinemia, inflammatory process activity, and endothelial dysfunction in patients with type 2 diabetes and acute coronary syndrome with ST elevation in relation to the severity of lesions in the coronary arteries].
Topics: Acute Coronary Syndrome; Adiponectin; Aged; Angioplasty, Balloon, Coronary; Atherosclerosis; Biomarkers; C-Reactive Protein; Case-Control Studies; Creatine Kinase, MB Form; Diabetes Mellitus, Type 2; Endothelial Cells; Female; Fibrinogen; Humans; Inflammation; Intercellular Adhesion Molecule-1; Male; Middle Aged; Severity of Illness Index; Troponin T; Vascular Cell Adhesion Molecule-1 | 2007 |
Effects of dietary protein restriction on albumin and fibrinogen synthesis in macroalbuminuric type 2 diabetic patients.
Topics: Adult; Albumins; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diet, Protein-Restricted; Dietary Proteins; Female; Fibrinogen; Humans; Leucine; Male; Middle Aged; Proteinuria; Treatment Outcome | 2008 |
Effects of androgen deprivation on glycaemic control and on cardiovascular biochemical risk factors in men with advanced prostate cancer with diabetes.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Comorbidity; Diabetes Mellitus, Type 2; Fibrinogen; Glycated Hemoglobin; Gonadotropin-Releasing Hormone; Humans; Male; Middle Aged; Prostatic Neoplasms; Retrospective Studies; Risk Factors; Triglycerides | 2007 |
Relation of plasma homocysteine levels to atherosclerotic vascular disease and inflammation markers in type 2 diabetic patients.
Topics: Aged; Atherosclerosis; Biomarkers; C-Reactive Protein; Diabetes Mellitus, Type 2; Fibrinogen; Homocysteine; Humans; Inflammation; Interleukin-6; Kidney Function Tests; Middle Aged; Tumor Necrosis Factor-alpha | 2008 |
Inflammatory markers, insulin resistance and carotid intima-media thickness in North-Indian type 2 diabetic subjects.
Topics: Age Factors; Biomarkers; C-Reactive Protein; Carotid Arteries; Carotid Artery Diseases; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; India; Inflammation; Insulin Resistance; Male; Middle Aged; Prospective Studies; Risk Factors; Tumor Necrosis Factor-alpha | 2007 |
The impact of metabolic syndrome and CRP on vascular phenotype in type 2 diabetes mellitus.
Topics: Aged; Biomarkers; C-Reactive Protein; Diabetes Mellitus, Type 2; E-Selectin; Female; Fibrinogen; Humans; Inflammation; Male; Metabolic Syndrome; Middle Aged; Phenotype; Plasminogen Activator Inhibitor 1; Thrombomodulin; Tissue Plasminogen Activator; Tunica Intima; Tunica Media; Vascular Cell Adhesion Molecule-1; von Willebrand Factor | 2008 |
The markers of inflammation and endothelial dysfunction in correlation with glycated haemoglobin are present in type 2 diabetes mellitus patients but not in their relatives.
Topics: Adult; Biomarkers; Blood Glucose; C-Reactive Protein; Diabetes Mellitus, Type 2; E-Selectin; Endothelium, Vascular; Female; Fibrinogen; Glycated Hemoglobin; Hemodynamics; Humans; Inflammation; Insulin; Intercellular Adhesion Molecule-1; Male; Middle Aged; Vascular Cell Adhesion Molecule-1 | 2008 |
Glycaemic control improves fibrin network characteristics in type 2 diabetes - a purified fibrinogen model.
Topics: Adult; Aged; Blood Glucose; Case-Control Studies; Cross-Linking Reagents; Diabetes Mellitus, Type 2; Elasticity; Factor XIIIa; Female; Fibrin; Fibrinogen; Fibrinolysis; Glycosylation; Humans; Hypoglycemic Agents; Insulin; Male; Microscopy, Confocal; Microscopy, Electron, Scanning; Middle Aged; Models, Biological | 2008 |
Effect of chlorpropamide and gliclazide on plasminogen activator activity in vascular walls in patients with maturity onset diabetes.
Topics: Aged; Chlorpropamide; Diabetes Mellitus, Type 2; Endothelium; Female; Fibrinogen; Fibrinolysis; Gliclazide; Humans; Liver; Male; Middle Aged; Muscle, Smooth, Vascular; Plasminogen Activators; Plasminogen Inactivators; Sulfonylurea Compounds | 1984 |
[Longitudinal studies on the prognostic significance of plasma fibrinogen in diabetes mellitus].
Topics: Coronary Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Humans; Hypertension; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Prognosis | 1984 |
[Blood viscosity and erythrocyte deformability in diabetic retinopathy].
Topics: Adult; Aged; Blood Viscosity; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Erythrocytes; Female; Fibrinogen; Hematocrit; Humans; Male; Middle Aged | 1983 |
[Lipid-metabolic and blood coagulation factors in chronic peripheral arteriopathies].
Topics: Adult; Aged; Antithrombin III; Arterial Occlusive Diseases; Chronic Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Humans; Lipids; Male; Middle Aged; Thrombocytosis | 1983 |
Diastolic dysfunction is not related to changes in glycaemic control over 6 months in type 2 (non-insulin-dependent) diabetes mellitus. A cross-sectional study.
Topics: Blood Glucose; Cholesterol; Diabetes Mellitus, Type 2; Diastole; Electrocardiography; Fibrinogen; Follow-Up Studies; Gated Blood-Pool Imaging; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Middle Aged; Reference Values; Systole; Time Factors; Triglycerides; Ventricular Function, Left | 1995 |
Blood coagulation and fibrinolysis in obese NIDDM patients.
Topics: Apolipoprotein A-I; Apolipoproteins B; Blood Coagulation; Blood Glucose; Body Mass Index; Body Weight; Cholesterol; Cholesterol, HDL; Diabetes Mellitus; Diabetes Mellitus, Type 2; Factor VII; Female; Fibrinogen; Fibrinolysis; Humans; Insulin; Lipoprotein(a); Male; Middle Aged; Obesity; Plasminogen; Reference Values; Tissue Plasminogen Activator; Triglycerides | 1994 |
Study on alteration of white blood cell deformability of NIDDM patients and the influencing factors.
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Female; Fibrinogen; Hemorheology; Humans; Leukocytes; Male; Middle Aged | 1994 |
Alteration of oxide reductive and haemostatic factors in type 2 diabetics.
Topics: Adult; Blood Coagulation Factors; Diabetes Mellitus, Type 2; Fatty Acids; Fibrinogen; Glutathione Peroxidase; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Phospholipids; Plasminogen Activator Inhibitor 1; Platelet Aggregation; Tissue Plasminogen Activator; von Willebrand Factor | 1994 |
[Fibrinolytic system in patients with myocardial infarction and other coronary disease risk factors].
Topics: Aged; alpha-2-Antiplasmin; Coronary Disease; Diabetes Mellitus, Type 2; Female; Fibrinogen; Fibrinolysis; Humans; Hyperlipidemias; Male; Middle Aged; Myocardial Infarction; Plasminogen; Plasminogen Activator Inhibitor 1; Plasminogen Activators; Risk Factors; Survivors | 1994 |
Thrombogenic factors are related to urinary albumin excretion rate in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients.
Topics: Adult; Aged; Albuminuria; Biomarkers; Blood Coagulation Factors; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Factor VII; Female; Fibrinogen; Humans; Lipid Peroxides; Male; Middle Aged; Protein C; Protein S; von Willebrand Factor | 1993 |
Decreased plasminogen activator inhibitor-1 activity in newly diagnosed type 2 diabetic patients following dietary modification.
Topics: Biomarkers; Blood Glucose; Blood Pressure; Cholesterol; Diabetes Mellitus, Type 2; Diet, Diabetic; Factor VII; Factor VIII; Fibrinogen; Glycated Hemoglobin; Humans; Middle Aged; Plasminogen Activator Inhibitor 1; Regression Analysis; Triglycerides | 1993 |
Elevation of factor XIa-alpha 1-antitrypsin complex levels in NIDDM patients with diabetic nephropathy.
Topics: Albuminuria; alpha 1-Antitrypsin; Antithrombin III; Biomarkers; Blood Glucose; Blood Pressure; Cholesterol; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Enzyme-Linked Immunosorbent Assay; Factor XIa; Female; Fibrinogen; Glycated Hemoglobin; Humans; Insulin; Male; Middle Aged; Regression Analysis; Thrombin; Triglycerides | 1993 |
Differences between plasma viscosity and proteins of types 1 and 2 diabetic Africans in early phase of diabetes.
Topics: Adult; Aged; Blood Proteins; Blood Viscosity; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Male; Middle Aged; Nigeria; Plasma; Serum Albumin; Vascular Diseases | 1993 |
Circadian variations in platelet aggregability in non insulin dependent diabetes patients (NIDDM).
Topics: Aged; Circadian Rhythm; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Insulin; Male; Middle Aged; Platelet Aggregation; Time Factors | 1993 |
Sex differences in coagulation and fibrinolysis in white subjects with non-insulin-dependent diabetes mellitus.
Topics: Aged; Antigens; Blood Coagulation; Body Mass Index; Cholesterol; Diabetes Mellitus, Type 2; Factor VII; Female; Fibrinogen; Fibrinolysis; Glycated Hemoglobin; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Sex Characteristics; Tissue Plasminogen Activator; von Willebrand Factor | 1996 |
Hypercoagulability and high lipoprotein(a) levels in patients with type II diabetes mellitus.
Topics: Aged; alpha-2-Antiplasmin; Antithrombin III; Blood Coagulation Disorders; Body Mass Index; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease Susceptibility; Female; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Japan; Lipoprotein(a); Male; Middle Aged; Peptide Hydrolases; Plasminogen Activator Inhibitor 1; Risk Factors; Tissue Plasminogen Activator | 1996 |
Risk factor analyses for macrovascular complication in nonobese NIDDM patients. Multiclinical Study for Diabetic Macroangiopathy (MSDM).
Topics: Aged; Blood Pressure; Cholesterol; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Humans; Japan; Male; Middle Aged; Regression Analysis; Risk Factors; Triglycerides | 1996 |
Plasma fibrinogen in NIDDM: the Rotterdam study.
Topics: Age Factors; Aged; Body Mass Index; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Fructosamine; Hexosamines; Humans; Hypertension; Hypoglycemic Agents; Insulin; Male; Middle Aged; Netherlands; Reference Values; Sex Characteristics; Sex Factors; Smoking | 1996 |
Influence of smoking on the survival rate of diabetic patients requiring hemodialysis.
Topics: Blood Pressure; Cardiovascular Diseases; Cerebrovascular Disorders; Cholesterol; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Female; Fibrinogen; Glycated Hemoglobin; Humans; Kidney Failure, Chronic; Male; Middle Aged; Prevalence; Renal Dialysis; Retrospective Studies; Risk Assessment; Risk Factors; Smoking; Survival Rate; Time Factors; Triglycerides | 1996 |
Angiopathy affects circulating endothelin-1 levels in type 2 diabetic patients.
Topics: Biomarkers; Blood Glucose; Blood Pressure; Body Mass Index; Cholesterol; Creatine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelins; Female; Fibrinogen; Humans; Male; Middle Aged; Reference Values; Regression Analysis; Triglycerides; Urea | 1995 |
Association of fibrinogen with glycemic control and albumin excretion rate in patients with non-insulin-dependent diabetes mellitus.
Topics: Adult; Aged; Albuminuria; Arteriosclerosis; Blood Glucose; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glycated Hemoglobin; Humans; Male; Middle Aged; Regression Analysis; Risk Factors | 1996 |
Plasma fibrinogen and its relationship to plasma sialic acid in non-insulin-dependent diabetes mellitus.
Topics: Aged; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Male; Middle Aged; N-Acetylneuraminic Acid | 1996 |
Circulating levels of factor VII, fibrinogen, and von Willebrand factor and features of insulin resistance in first-degree relatives of patients with NIDDM.
Topics: Adult; Diabetes Mellitus, Type 2; Exons; Factor VII; Family Health; Female; Fibrinogen; Genotype; Humans; Insulin Resistance; Male; Middle Aged; Polymorphism, Genetic; Promoter Regions, Genetic; Risk Factors; von Willebrand Factor | 1996 |
Physiological inhibitors of blood coagulation and prothrombin fragment F 1 + 2 in type 2 diabetic patients with normoalbuminuria and incipient nephropathy.
Topics: Albuminuria; Anticoagulants; Antithrombin III; Blood Coagulation Factors; Blood Pressure; Body Mass Index; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Fibrinogen; Humans; Male; Middle Aged; Peptide Fragments; Protein C; Protein Precursors; Protein S; Prothrombin; Thrombomodulin; Triglycerides | 1996 |
Beta-fibrinogen gene-455 G/A polymorphism and fibrinogen levels. Risk factors for coronary artery disease in subjects with NIDDM.
Topics: Adenine; Aged; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Genotype; Guanine; Humans; Hypertension; Male; Middle Aged; Polymorphism, Genetic; Risk Factors | 1996 |
Protein C activation in NIDDM patients.
Topics: Adult; Aged; Blood Coagulation; Cohort Studies; Diabetes Mellitus, Type 2; E-Selectin; Enzyme Activation; Female; Fibrinogen; Humans; Male; Middle Aged; Peptide Fragments; Protein C; Protein C Inhibitor; Protein Precursors; Prothrombin; Reference Values; Thrombomodulin | 1996 |
The influence of diabetes on the vasomotor responses of saphenous vein and the development of infra-inguinal vein graft stenosis.
Topics: Aged; Aged, 80 and over; Amputation, Surgical; Blood Vessel Prosthesis; Bradykinin; Calcimycin; Collagen; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium, Vascular; Female; Fibrinogen; Humans; In Vitro Techniques; Indomethacin; Ischemia; Leg; Male; Microscopy, Electron; Middle Aged; NG-Nitroarginine Methyl Ester; Postoperative Complications; Saphenous Vein; Time Factors; Vascular Diseases; Vascular Surgical Procedures; Vasodilation | 1997 |
Effect of bezafibrate on hypercoagulability assessed by fluorogenic prothrombin time in hyperlipidemic patients with non-insulin-dependent diabetes mellitus.
Topics: Aged; Bezafibrate; Blood Coagulation; Body Mass Index; Case-Control Studies; Cholesterol; Diabetes Mellitus, Type 2; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Glycated Hemoglobin; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Prothrombin Time | 1997 |
Role of leukocytes in diabetic microcirculatory disturbances.
Topics: Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fibrinogen; Hematocrit; Hemorheology; Humans; Leukocytes; Membrane Fluidity; Microcirculation; Microscopy, Video; Plasma; Pressure; Reproducibility of Results; Suspensions | 1997 |
Fibrinogen and albuminuria are related to the presence and severity of peripheral arterial disease in women with type 2 diabetes mellitus.
Topics: Aged; Albuminuria; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Humans; Lipids; Middle Aged; Peripheral Vascular Diseases; Regression Analysis; Risk Factors | 1997 |
Total plasma antioxidant capacity predicts thrombosis-prone status in NIDDM patients.
Topics: Antioxidants; Ascorbic Acid; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Peptide Fragments; Predictive Value of Tests; Protein Precursors; Prothrombin; Reference Values; Regression Analysis; Risk Factors; Thrombosis; Uric Acid; Vitamin A; Vitamin E | 1997 |
Glycaemic control and cardiovascular risk factors in type 2 diabetes: a population-based study.
Topics: Blood Glucose; Cholesterol; Cohort Studies; Diabetes Complications; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Glycated Hemoglobin; Humans; Hypertension; Hypoglycemic Agents; Male; Obesity; Risk Factors; Triglycerides | 1998 |
Alterations in erythrocyte aggregability in diabetics: the influence of plasmatic fibrinogen and phospholipids of the red blood cell membrane.
Topics: Adult; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Erythrocyte Aggregation; Erythrocyte Membrane; Female; Fibrinogen; Humans; Male; Middle Aged; Phospholipids | 1998 |
Effect of intensive glycaemic control on fibrinogen plasma concentrations in patients with Type II diabetes mellitus. Relation with beta-fibrinogen genotype.
Topics: Blood Glucose; C-Reactive Protein; Deoxyribonuclease HindIII; Diabetes Mellitus, Type 2; Female; Fibrinogen; Genotype; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length | 1998 |
Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS).
Topics: Arteriosclerosis; Asian People; Black People; Diabetes Mellitus, Type 2; Female; Fibrinogen; Fibrinolysis; Glucose Tolerance Test; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Proinsulin; Regression Analysis; Risk Factors; White People | 1999 |
Enhanced erythrocyte aggregation in type 2 diabetes with late complications.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Erythrocyte Aggregation; Female; Fibrinogen; Hemorheology; Humans; Male; Middle Aged | 1999 |
Circulating thrombomodulin and hematological alterations in type 2 diabetic patients with retinopathy.
Topics: Aged; Aged, 80 and over; alpha-2-Antiplasmin; Antifibrinolytic Agents; Antithrombin III; Biomarkers; Blood Glucose; Case-Control Studies; Creatinine; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Endothelium, Vascular; Female; Fibrinogen; Fibrinolysin; Humans; Lipids; Male; Middle Aged; Multivariate Analysis; Peptide Hydrolases; Predictive Value of Tests; Thrombomodulin; Tunica Intima; von Willebrand Factor | 1998 |
Association of plasma fibrinogen level and blood pressure with diabetic retinopathy, and renal complications associated with proliferative diabetic retinopathy, in Type 2 diabetes mellitus.
Topics: Aged; Blood Pressure; Blood Viscosity; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; Female; Fibrinogen; Humans; Logistic Models; Male; Middle Aged | 1999 |
Circulating levels of interleukin-6, its soluble receptor and interleukin-6/interleukin-6 receptor complexes in patients with type 2 diabetes mellitus.
Topics: Adult; Aged; Biomarkers; Blood Glucose; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Fibrinogen; Humans; Interleukin-6; Middle Aged; Receptors, Interleukin-6; Reference Values; Regression Analysis; Triglycerides | 1999 |
Beta-fibrinogen gene G/A-455 polymorphism in relation to fibrinogen concentrations and ischaemic heart disease in Chinese patients with type II diabetes.
Topics: Age Factors; Alleles; Body Mass Index; China; Cohort Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Gene Frequency; Genetic Linkage; Genetic Predisposition to Disease; Genotype; Humans; Logistic Models; Male; Middle Aged; Myocardial Ischemia; Polymorphism, Genetic; Risk Factors; Sex Factors; Smoking | 1999 |
Evidence of islet cell autoimmunity in elderly patients with type 2 diabetes.
Topics: Aged; Aged, 80 and over; Aging; Autoantibodies; Autoantigens; Autoimmunity; Blood Glucose; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glucose Tolerance Test; Glutamate Decarboxylase; Humans; Islets of Langerhans; Male; Membrane Proteins; Protein Tyrosine Phosphatases; Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 2000 |
Haemostasis and carotid artery wall thickness in non-insulin dependent diabetes mellitus.
Topics: Age Distribution; Carotid Arteries; Carotid Artery Diseases; Diabetes Mellitus, Type 2; Female; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Prevalence; Prospective Studies; Risk Factors; Sex Distribution | 2000 |
[Diabetes mellitus and fibrinogen. Hemorrheological and microcirculatory consequences].
Topics: Adult; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Erythrocyte Aggregation; Female; Fibrinogen; Hemorheology; Humans; Male; Microcirculation; Middle Aged | 2000 |
Variations and clinical significance of coagulation and fibrinolysis parameters in patients with diabetes mellitus.
Topics: Adult; Aged; Antithrombin III; Blood Coagulation; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Thrombophilia | 1998 |
Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels.
Topics: Adult; Blood Glucose; Cholesterol; Cholesterol, HDL; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Insulin; Male; Middle Aged; Nuclear Family; Plasminogen Activator Inhibitor 1; Tissue Plasminogen Activator; Triglycerides | 2000 |
Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study.
Topics: Apolipoproteins; Body Constitution; Cholesterol, HDL; Coronary Disease; Diabetes Mellitus, Type 2; Factor VIII; Female; Fibrinogen; Follow-Up Studies; Humans; Incidence; Leukocyte Count; Male; Middle Aged; Prospective Studies; Risk Factors; Serum Albumin; von Willebrand Factor | 2000 |
Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study.
Topics: Albuminuria; Arteriosclerosis; Biomarkers; Blood Pressure; Body Mass Index; C-Reactive Protein; Creatinine; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glucose Tolerance Test; Humans; Hypertension, Renal; Insulin Resistance; Kidney Failure, Chronic; Male; Middle Aged; Nephritis | 2000 |
Hyperfibrinogenaemia did not improve after treating hyperglycaemia in Chinese type 2 diabetic patients.
Topics: Adult; Body Mass Index; China; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glycated Hemoglobin; Humans; Hyperglycemia; Male; Middle Aged; Risk Factors; Statistics as Topic; Triglycerides | 2000 |
Thermographic measurement of skin temperature recovery time of extremities in patients with type 2 diabetes mellitus.
Topics: Analysis of Variance; Arteriosclerosis; Blood Pressure; Cold Temperature; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Humans; Japan; Male; Middle Aged; Neural Conduction; Plasminogen Activator Inhibitor 1; Reference Values; Regression Analysis; Skin Temperature; Thermography; Time Factors; Toes | 2000 |
Fibrinogen, other cardiovascular risk factors and diabetes mellitus in Hong Kong: a community with high prevalence of Type 2 diabetes mellitus and impaired glucose tolerance.
Topics: Adult; Age Factors; Aged; Asian People; Blood Pressure; Cardiovascular Diseases; Cholesterol, HDL; Confidence Intervals; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glucose Intolerance; Hong Kong; Humans; Hypertension; Male; Middle Aged; Obesity; Prevalence; Risk Factors; Sex Factors; Triglycerides | 2000 |
A global platelet test of thrombosis and thrombolysis detects a prothrombotic state in some patients with non-insulin dependent diabetes and in some patients with stroke.
Topics: Adult; Age Factors; Aged; Antifibrinolytic Agents; Arteriosclerosis; Diabetes Mellitus, Type 2; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Function Tests; Stress, Mechanical; Stroke; Thrombophilia | 2000 |
Carotid intima-media thickness in patients with Type 2 diabetes and hypercholesterolemia.
Topics: Age Factors; Arteriosclerosis; Carotid Artery, Common; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Hypercholesterolemia; Male; Middle Aged; Risk Factors; Time Factors; Tunica Intima | 2001 |
Relationship between plasma soluble thrombomodulin levels and insulin resistance syndrome in type 2 diabetes: a comparison with von Willebrand factor.
Topics: Adult; Aged; Blood Pressure; Cholesterol, HDL; Diabetes Mellitus, Type 2; Diet; Female; Fibrinogen; Homeostasis; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Middle Aged; Models, Biological; Solubility; Sulfonylurea Compounds; Thrombomodulin; von Willebrand Factor | 2001 |
Insulin resistance as a major determinant of increased coronary heart disease risk in postmenopausal women with Type 2 diabetes mellitus.
Topics: Absorptiometry, Photon; Adipose Tissue; Aged; Albuminuria; Blood Glucose; Blood Pressure; Cholesterol; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Electrocardiography; Factor VII; Female; Fibrinogen; Homeostasis; Humans; Insulin; Insulin Resistance; Lipoproteins; Lipoproteins, LDL; Middle Aged; Models, Biological; Plasminogen Activator Inhibitor 1; Postmenopause; Proinsulin; Risk Factors; Triglycerides | 2001 |
Monitoring of cardiovascular risk factors in the diabetic clinics of an Italian region: the MOFRAD study.
Topics: Adult; Aged; Ambulatory Care Facilities; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cholesterol; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Italy; Lipoproteins, HDL; Male; Middle Aged; Obesity; Risk Factors; Sex Characteristics; Smoking; Triglycerides | 2001 |
Relationship between plasma Endothelin-1 and glycemic control in type 2 diabetes mellitus.
Topics: Adult; Blood Glucose; Blood Pressure; Body Mass Index; Cholesterol; Diabetes Mellitus, Type 2; Endothelin-1; Female; Fibrinogen; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Triglycerides | 2001 |
Impaired hemorheological properties in diabetic patients with lower limb arterial ischaemia.
Topics: Adult; Aged; Arteries; Blood Gas Monitoring, Transcutaneous; Blood Viscosity; Case-Control Studies; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Erythrocyte Aggregation; Female; Fibrinogen; Hemorheology; Humans; Hypoxia; Ischemia; Leg; Male; Middle Aged; Serum Albumin | 2001 |
Relationship of abdominal fat with metabolic disorders in diabetes mellitus patients.
Topics: Abdomen; Adipose Tissue; Aged; Albuminuria; Antithrombin III; Blood Coagulation Disorders; Blood Pressure; Body Composition; Cholesterol, HDL; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Female; Fibrinogen; Humans; Insulin; Male; Middle Aged; Peptide Hydrolases; Regression Analysis; Sex Characteristics; Triglycerides; Viscera | 2002 |
Lack of an association of urinary albumin excretion with interleukin-6 or C-reactive protein in patients with type 2 diabetes.
Topics: Albuminuria; C-Reactive Protein; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Erythrocyte Aggregation; Female; Fibrinogen; Humans; Interleukin-6; Male; Middle Aged; Statistics, Nonparametric | 2001 |
Rheological determinants of red blood cell aggregation in diabetic patients in relation to their metabolic control.
Topics: Acute-Phase Proteins; Blood Glucose; Blood Sedimentation; C-Reactive Protein; Cell Adhesion; Cell Aggregation; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Erythrocytes; Female; Fibrinogen; Hemorheology; Humans; In Vitro Techniques; Leukocyte Count; Male; Sensitivity and Specificity; Triglycerides | 2002 |
[Study of platelet membrane glycoproteins and its fibrinogen binding reaction in patients with cerebral infarction and diabetes mellitus].
Topics: Adult; Aged; Cerebral Infarction; Diabetes Mellitus, Type 2; Female; Fibrinogen; Flow Cytometry; Humans; Integrin beta3; Male; Middle Aged; P-Selectin; Platelet Glycoprotein GPIb-IX Complex; Platelet Membrane Glycoprotein IIb; Platelet Membrane Glycoproteins | 2000 |
Impaired fibrinolytic compensation for hypercoagulability in obese patients with type 2 diabetes: association with increased plasminogen activator inhibitor-1.
Topics: Administration, Oral; Blood Coagulation; Body Mass Index; Cholesterol; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Hypoglycemic Agents; Male; Middle Aged; Obesity; Plasminogen Activator Inhibitor 1; Reference Values; Regression Analysis; Triglycerides | 2002 |
Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.
Topics: Acute-Phase Proteins; Arteriosclerosis; Body Mass Index; C-Reactive Protein; Diabetes Mellitus, Type 2; Ethnicity; Fasting; Female; Fibrinogen; Glucose Tolerance Test; Humans; Hypertension; Incidence; Insulin; Insulin Resistance; Insulin Secretion; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Predictive Value of Tests; Regression Analysis; Smoking; United States | 2002 |
Impaired fibrinolysis in premenopausal women and age-matched men with Type 2 diabetes mellitus: a pilot study.
Topics: Adult; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Fibrinogen; Fibrinolysis; Humans; Male; Pilot Projects; Plasminogen Activator Inhibitor 1; Premenopause; Serum Globulins; Sex Characteristics; Tissue Plasminogen Activator | 2002 |
Effect of acupuncture on plasmic levels of insulin, glucagon and hypercoagulability in NIDDM complicated by acute cerebral infarction.
Topics: Acupuncture Therapy; Cerebral Infarction; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glucagon; Humans; Insulin; Male; Middle Aged; Platelet Aggregation | 2001 |
Hyperfibrinogenemia. An important risk factor for vascular complications in diabetes.
Topics: Analysis of Variance; Blood Glucose; Cholesterol; Cholesterol, HDL; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Glycated Hemoglobin; Humans; Hypertension; Male; Middle Aged; Multivariate Analysis; Obesity; Reference Values; Risk Factors; Triglycerides | 1992 |
Hematologic changes in type 2 diabetic patients with various localizations of peripheral vascular disease.
Topics: Arteriosclerosis Obliterans; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Hematocrit; Hemoglobinometry; Humans; Ischemia; Leg; Leukocyte Count; Male; Middle Aged; Platelet Count | 1992 |
Increased plasminogen activator inhibitor antigen levels in diabetic patients with stable angina.
Topics: Adult; Aged; Angina Pectoris; Antithrombin III; Coronary Disease; Diabetes Mellitus, Type 2; Exercise Test; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Peptide Hydrolases; Plasminogen Inactivators; Tissue Plasminogen Activator | 1991 |
Do rheological variables play a role in diabetic peripheral neuropathy?
Topics: Blood Viscosity; Body Mass Index; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Erythrocyte Deformability; Female; Fibrinogen; Glycated Hemoglobin; Hematocrit; Humans; Male; Middle Aged; Reference Values | 1991 |
Activation of coagulation in diabetes mellitus in relation to the presence of vascular complications.
Topics: Adult; Blood Coagulation; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Factor VII; Factor VIIa; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Glycated Hemoglobin; Hemostasis; Humans; Male; Middle Aged; Smoking | 1991 |
Euglobulin fibrinolytic activity in NIDDM patients.
Topics: Age Factors; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Fibrinogen; Fibrinolysis; Glycated Hemoglobin; Humans; Lipids; Male; Middle Aged; Proteinuria; Reference Values; Regression Analysis; Serum Globulins | 1991 |
Evaluation of red cell deformability by a filtration method in type 1 and type 2 diabetes mellitus with and without vascular complications.
Topics: Adult; Aged; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Erythrocyte Deformability; Female; Fibrinogen; Filtration; Glycated Hemoglobin; Hematocrit; Hemoglobins; Humans; Leukocyte Count; Male; Middle Aged; Reference Values; Serum Globulins; Smoking | 1990 |
Hemostatic alterations with exercise conditioning in NIDDM.
Topics: Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Fibrinogen; Fibrinolysis; Fibronectins; Glucose Tolerance Test; Humans; Male; Middle Aged; Physical Exertion; Plasminogen; Tissue Plasminogen Activator | 1990 |
[Tissue-type plasminogen activator and its inhibitor (PAI-1) in plasma in cases of non-insulin-dependent diabetes mellitus (NIDDM)].
Topics: Adult; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Female; Fibrinogen; Fibrinolysis; Humans; Male; Plasminogen Inactivators; Tissue Plasminogen Activator | 1990 |
Plasma fibrinogen levels in type II diabetics.
Topics: Albuminuria; Blood Glucose; Cholesterol; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fibrinogen; Glycated Hemoglobin; Humans; Immunoassay; Risk Factors | 1990 |
Haemostatic measures in type 2 diabetic patients with microalbuminuria.
Topics: Aged; Albuminuria; Blood Glucose; Blood Pressure; Creatinine; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Fibrinogen; Fibronectins; Glycated Hemoglobin; Humans; Middle Aged; Reference Values; von Willebrand Factor | 1990 |
Branch retinal vein occlusion: the pathogenetic role of blood viscosity.
Topics: Adult; Aged; Aged, 80 and over; Blood Viscosity; Diabetes Mellitus, Type 2; Erythrocyte Deformability; Female; Fibrinogen; Fluorescein Angiography; Fundus Oculi; Hematocrit; Humans; Hypertension; Male; Middle Aged; Retinal Vein Occlusion | 1990 |
Different levels of cardiovascular risk factors in type-2 diabetic patients with lower limb proximal and distal vessel macroangiopathy.
Topics: Apolipoproteins B; Cholesterol; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fibrinogen; Humans; Leg; Risk Factors; Ultrasonography | 1990 |
Comparison of plasma viscosity and fibrinogen concentration in African insulin-dependent and non-insulin-dependent diabetics with and without hypertension.
Topics: Aged; Blood Viscosity; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Hypertension; Male; Middle Aged; Random Allocation | 1990 |
Effects of pentoxifylline on proteinuria in normotensive patients with diabetes mellitus.
Topics: Adult; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Fibrinogen; Humans; Male; Middle Aged; Pentoxifylline; Proteinuria | 1990 |
[Behavior of fibrinogen in diabetic patients in comparison with objective vascular measurements in the ocular fundus].
Topics: Adolescent; Adult; Blood Flow Velocity; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Fibrinogen; Fluorescein Angiography; Humans; Male; Middle Aged; Retinal Vessels | 1985 |
Effects of Chinese medicinal herbs on hemorheology in diabetics.
Topics: Adult; Blood Viscosity; Diabetes Mellitus, Type 2; Drugs, Chinese Herbal; Erythrocyte Deformability; Female; Fibrinogen; Hematocrit; Humans; Male; Medicine, Chinese Traditional; Middle Aged; Rheology | 1989 |
PARD: platelet aggregation as a risk factor in diabetics: results of a prospective study.
Topics: Aged; beta-Thromboglobulin; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Factor VIII; Female; Fibrinogen; Glycosuria; Humans; Male; Middle Aged; Platelet Aggregation; Prospective Studies; Reference Values; Risk; Sex Factors | 1985 |
Impaired fibrinolytic response to exercise in type II diabetes: effects of exercise and physical training.
Topics: Adult; Blood Coagulation; Blood Coagulation Tests; Diabetes Mellitus, Type 2; Exercise; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Oxygen Consumption; Physical Education and Training; Prothrombin Time | 1988 |
Diabetic hypertension--the importance of fibrinogen and blood viscosity.
Topics: Blood Viscosity; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Hypertension; Male; Middle Aged; Sex Factors; Smoking | 1988 |
Haemostasiological parameters as risk factor for new arterial occlusions in diabetics.
Topics: Aged; Arterial Occlusive Diseases; Blood Coagulation Tests; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Humans; Male; Middle Aged; Platelet Aggregation; von Willebrand Factor | 1986 |
Effects of long-term treatment (4 years) with pentoxifylline on haemorheological changes and vascular complications in diabetic patients.
Topics: Adult; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Erythrocyte Deformability; Female; Fibrinogen; Humans; Male; Middle Aged; Pentoxifylline; Theobromine | 1987 |
Fibrinogen interaction with platelets of diabetic subjects.
Topics: Adenosine Diphosphate; Adult; Aged; Alprostadil; Antibodies, Monoclonal; Binding Sites; Blood Platelets; Chymotrypsin; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Membrane Glycoproteins; Reference Values | 1987 |
Plasma fibrinogen in a diabetic population.
Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Male | 1986 |
The effects of oral stanozolol on fibrinolysis in type 2 diabetes mellitus.
Topics: Administration, Oral; Adult; Aged; alpha-2-Antiplasmin; Diabetes Mellitus, Type 2; Fibrinogen; Fibrinolysis; Humans; Middle Aged; Plasminogen; Research Design; Stanozolol | 1986 |
[Hemorheologic studies for evaluating microcirculation in patients with peripheral arterial circulatory disorders and diabetes mellitus].
Topics: Adult; Aged; Arterial Occlusive Diseases; Blood Viscosity; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Erythrocyte Aggregation; Erythrocyte Deformability; Fibrinogen; Hematocrit; Humans; Ischemia; Leg; Male; Microcirculation; Middle Aged; Rheology | 1986 |
Fibrinopeptide-A in diabetes mellitus. Relation to levels of blood glucose, fibrinogen disappearance, and hemodynamic changes.
Topics: Adolescent; Adult; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Fibrinopeptide A; Glucose; Hemodynamics; Humans; Male; Middle Aged | 1985 |
Diabetic retinal vascular complications and erythrocyte filtrability; results of a 2-year follow-up study with pentoxifylline.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Erythrocyte Deformability; Female; Fibrinogen; Follow-Up Studies; Glycated Hemoglobin; Humans; Male; Middle Aged; Pentoxifylline; Proteinuria; Theobromine; Time Factors | 1985 |
[Biochemical aspects of the pathogenesis of the late diabetic syndrome].
Topics: Apoproteins; Blood Glucose; Collagen; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Fibrinogen; Glycated Hemoglobin; Humans; Membrane Proteins; Myelin Proteins; Serum Albumin | 1985 |